The Evolution of Antagonistic Social Interactions in Bacteria: an Investigation of Spite, Competition, and Virulence in Xenorhabdus Spp by Bhattacharya, Amrita
THE EVOLUTION OF ANTAGONISTIC SOCIAL INTERACTIONS IN BACTERIA: AN 
























Submitted to the faculty of the University Graduate School 
in partial fulfillment of the requirements 
for the degree 
Doctor of Philosophy 




Accepted by the Graduate Faculty, Indiana University, in partial 




Farrah Bashey-Visser, Ph.D. (Co-Chairperson) 
 
______________________________________ 
Curtis M. Lively, Ph.D. (Co-Chairperson) 
 
______________________________________ 
Lynda F. Delph, Ph.D. 
 
______________________________________ 
Michael J. Wade, Ph.D. 






A famous African proverb says ‘it takes a village to raise a child’. I think this proverb beautifully 
captures the essence developing a dissertation as well. Here I express my gratitude to the 
‘village’ that made this dissertation possible.  
 
First and foremost I’d like to thank my Ph.D. advisors Farrah Bashey and Curt Lively. I consider 
myself extremely fortunate to have had not one but two amazing scientists and human beings as 
my Ph.D. mentors. Farrah’s incredibly sharp mind and deep thinking continually inspires me. 
Over the years, I have remained in awe of the way Farrah can approach a question from multiple 
perspectives and offer novel insights and ideas. In addition to being a brilliant scientist, Farrah is 
one of the most dedicated and committed teachers I know, and a very generous and 
compassionate person. I could not be prouder to have the distinct honor of being the first Ph.D. 
student in your lab, Farrah. Thank you for taking me on and helping me grow as a scientist and a 
person.  
 
This dissertation, and my growth as a scientist over the last six years would not have been 
possible without the mentorship of Curt Lively. Curt’s mentorship has helped me see myself as a 
scientist and believe that I am capable of pursuing my ambitions, for which I will remain 
eternally grateful. Working with Curt has taught me to never lose sight of the big questions, be 
meticulous in my work, and be clear and direct in my communication. I have learned an 
incredible amount about science and life, and perhaps most importantly, about being a good 
person from Curt. This acknowledgement would be sorely incomplete without thanking Curt for 
 iv 
introducing me to country music and mandolins!! You have made Bloomington home to me and 
I may never be able to express how lucky I feel to know you. Thank you, Curt. 
 
I would like to thank my committee members Lynda Delph and Mike Wade for their thoughtful 
and constructive suggestions during my committee meetings. Despite being on my committee 
only during the last two years, Lynda’s suggestions have importantly shaped the way I made 
decisions about projects and used my time. Lynda has also generously helped me with comments 
and her incredible (I want to say magical) proof-reading skills to edit a manuscript and improve 
this dissertation. Thank you,  Lynda. I would also like to thank Mike Wade for inspiring me to 
think broadly, and helping me understand the potential scope of the work described in this 
dissertation. I have also thoroughly enjoyed working with Mike as an Associate Instructor. I 
would also like to thank Jim Bever and Keith Clay for very engaging discussions and ideas when 
they had been on my thesis committee before moving from IU. I’d also like to thank the entire 
IU EEB community for creating such a supportive and inspiring space for graduate students.  
 
I would like to thank all my undergraduate collaborators: Hannah Pak, Alexander Stacy, Valeria 
C Toro Diaz, and Sarah Montgomery for their important contributions to the projects we have 
worked on together. I am thrilled to have had the chance to work with each of them and to get 
the opportunity to learn about mentoring. This work would not have been possible without 
funding from numerous sources. I would like to take this opportunity to thank CISAB at Indiana 
University for offering a predoctoral fellowship which is open to international students, such as 
myself, who have fairly limited access to fellowship applications. I would also like to 
acknowledge the Society for the Study of Evolution, Sigma-Xi, and the IU College of Arts and 
 v 
Sciences for supporting my research through various research funds. This dissertation would also 
not have been the same without support from the Biology Department Staff, Graduate Office, 
and the Office of International Studies at Indiana University.  
 
I would like to thank Levi Morran and Maurine Neiman for being excellent collaborators and 
mentors. I had the opportunity to overlap with Levi during my first semester at IU when I was 
doing a rotation in the Lively lab. Ever since then Levi has been an excellent teacher, friend, and 
guide to me even from a distance when he set up his own amazing lab at Emory University. I 
was thrilled to get a chance to formally collaborate with Levi on the project that is now Chapter 3 
of this dissertation. Maurine Neiman, has been an amazing mentor and friend. I am grateful to 
Maurine for opening up her lab to me, for her patience and support as I was venturing into a 
completely new area of work, and for her tireless enthusiasm for science and life. Meeting 
Maurine and little JJ (who was 3 months old when I first met him) was definitely one of the 
highlights of my graduate career. Thank you, Levi, Maurine, and JJ! 
 
I’m incredibly grateful to Zoe Dinges, Kara Million, and Ashwini Ramesh for being fantastic 
lab-mates. Zoe is one of the kindest, most supportive, and most hard-working scientists I have 
ever known. Zoe’s grandma Bobbie (whom I also call grandma), is a force to reckon with and an 
inspiration to all. I feel lucky to know these amazing women. Kara is a great friend and inspires 
me every day with her grit, determination, and never-say-never attitude. Ashwini is a fearless 
scientist and thoughtful friend whose positivity is infectious! Each of these brilliant women are 
doing great science and I am looking forward to following all the interesting discoveries they 
 vi 
make. I’d also like to thank Mandy Gibson, Sam Slowinski, and Amy Dapper – former labbies 
and pathbreakers for being very supportive lab mates and friends through the years. 
 
I feel fortunate to have had a warm and friendly community in Bloomington that made me feel at 
home through all the ups and downs of graduate school. This journey would not have been the 
same without the friendship of Jesualdo Fuentez-Gonzalez, Paris Veltsos, Wen-Juan Ma, Abby 
Kimmitt, Adrienne Keller, Rachel Hanauer, Maja Sljivar, Delaney Miller, and Devraj Singh. I’d 
like to thank my wonderful neighbors Mrs. Susan Goddard and Mr. Casey Fredericks for their 
cheer and warmth. I would also like to say a huge thank you to Ellen Ketterson for being such an 
inspiration to me and for her generous friendship throughout the years. I know I have thanked 
Curt and Lynda previously but I would be remiss to not thank them here for being parent-figures 
to me during my time here. I would also like to take this opportunity to thank Mark Wells whose 
music, friendship, and support I cherish deeply. Finally, I would like to thank two very special 
friends: Shreya Ghosh and Nitya Mohan who, despite being far away ( in India and Germany 
respectively) have made an important difference in my life throughout my years in graduate 
school. Thank you all. 
 
I’m indebted to some fantastic mentors along the way who have made my journey in science 
possible. I’d like to thank Prof. R. P. Phadke, Head of the Microbiology Department in Ruia 
College for being the first person to introduce me to scientific thinking. Prof. Phadke’s approach 
to teaching inspired me to apply to summer research internship programs as an undergraduate 
and led me to work with Prof. Amitabh Joshi at JNCASR, Bangalore. If there ever has been a 
turning point in my life, it was working with Prof. Joshi whose mentorship inspired me to pursue 
 vii 
science as a career and who has had a huge influence in shaping the way I do science. Thank 
you, Sir.  
 
To conclude, I would like to thank four very special people whose love and support continually 
inspire me. My parents, Tapan and Moonmoon Bhattacharyya for supporting my career and life 
choices despite the fact that it meant their only child would be half way across the world from 
them. I am very lucky to have such loving and supportive parents and there isn’t enough I can 
say to express my gratitude for their love, support, and enthusiasm for my accomplishments. 
Thank you, Ma-Baba. I want to acknowledge my best friend Dr. Varsha Venkataraman for her 
relentless support, tireless enthusiasm, and true friendship. She has been my rock during some of 
the most challenging times of my life and I would not be the person I am today without her 
support. Her zest for life and impossible-is-nothing attitude inspire me every single day. Thank 
you, Varsha. Finally, I would like to thank my partner Jon Zarling for all his support, kindness, 
and encouragement as we both defended our dissertations within weeks of each other. Thank you 




THE EVOLUTION OF ANTAGONISTIC SOCIAL INTERACTIONS IN BACTERIA: AN 
INVESTIGATION OF SPITE, COMPETITION, AND VIRULENCE IN XENORHABDUS SPP 
 
This dissertation examines the evolution of a spiteful bacterial trait, bacteriocin 
production using insect-pathogenic bacteria in the genus Xenorhabdus.  Bacteriocins are 
anticompetitor toxins produced by almost all known lineages of bacteria. Bacteriocin production 
is considered spiteful because it is costly to the producer; it also results in the killing of 
competiting strains of bacteria. Moreover, the costs of production are often too great to outweigh 
the direct benefits of competitor killing. Many costly traits in nature are maintained by being 
phenotypically plastic, and expressed only in environmental contexts where the benefits 
outweigh the costs. However, the role of competition-induced plasticity in the evolution of 
bacteriocin production has been largely untested. I empirically tested whether bacteriocin 
production is induced in response to the presence of non-self competitors, in a natural 
Xenorhabdus isolate (Chapter 1). Surprisingly, I found no evidence to support the plasticity 
hypothesis. This result was particularly puzzling because bacteriocin production in gram-
negative bacteria like Xenorhabdus is often considered a ‘suicide mission’ where cell lysis is 
required for toxin release. Why would bacteriocin-producing cells commit ‘suicide’ in the 
absence of any competitors? To address this question, I used a modeling approach and examined 
the simplest conditions necessary for costly bacteriocin production to invade a metapopulation of 
faster-growing, sensitive cells (Chapter 2). Results show that bacteriocin release by lysis upon 
natural cell death can be sufficient for bacteriocin production to be favored; thus, competitor-
induced plasticity is not necessary for bacteriocin production to be maintained.  
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Next, I examined the consequences of spiteful bacteriocin production on disease. Owing 
to their substantial growth costs, spiteful behaviors are predicted to reduce within-host pathogen 
growth and thereby pathogen virulence, which is the degree of damage a pathogen causes to its 
host. Consistent with predictions, I found evidence for reduced levels of bacteriocin production 
in experimentally evolved lineages that show greater virulence (Chapter 3). Finally, I 
investigated the evolution of bacteriocin resistance and showed that the incorporation of live, 
heterospecific competitors in conjunction with bacteriocin doses can reduce the emergence of 
bacteriocin resistance in vitro (Chapter 4). In the face of the current antimicrobial resistance 
crisis, these results provide strong proof-of-concept for a novel approach to impede the 
emergence of resistance against alternative antimicrobials such as bacteriocins. Taken together, 
this dissertation provides novel insights into the evolution and maintenance of bacteriocins in 
pathogenic bacteria, and attests to the importance of social interactions in shaping pathogen 
evolution. 
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The Evolution of Antagonistic Social Interactions in Bacteria : An Investigation of 
Spite, Competition, and Virulence in Xenorhabdus spp. 
 
Social interactions can profoundly impact the fitness of organisms (Hamilton, 1964a; b; 
Frank, 1998). Growing evidence suggests that even simple unicellular microbes and viruses 
exhibit a diverse array of complex and sophisticated social interactions (Crespi, 2001; West et 
al., 2007a; Strassmann et al., 2011; Díaz-Muñoz et al., 2017). Besides being fascinating in their 
own right, social interactions among microorganisms are of interest to biologists for a few 
distinct reasons. Microbial social interactions offer an excellent opportunity to test the generality 
of social evolution theory (West et al., 2006, 2007a). Their short generation times makes 
microorganisms amenable to long-term evolutionary experimentation, and the ease of genetic 
manipulation further expands the scope of questions that can be addressed using these systems 
(West et al., 2007a). Moreover, when these microbes are pathogenic, their social traits can have 
substantial impact on disease, and offer novel opportunities for disease management (Foster, 
2005; Brown et al., 2009; Leggett et al., 2014). Owing to their potential for illuminating the 
evolution of social behaviors and their impact on disease, understanding the social lives of 
microorganisms, especially pathogens, has attracted considerable scientific attention over the 
past few decades.  
 
 A ubiquitously expressed social trait in bacteria, including pathogenic bacteria, is the 






related competitor strains, but do not kill clonemates of the producing cell (Reeves, 1965; Riley 
& Chavan, 2006). These ribosomally synthesized antimicrobial peptides exhibit a wide range of 
killing mechanisms including enzyme inhibition, nuclease activity, and pore formation in cell 
membranes (Riley & Wertz, 2002a; Riley & Chavan, 2006). Despite the competitive benefits of 
bacteriocin production, the synthesis and release of such large, proteinaceous toxins imposes 
high growth costs, and bacteriocin release often requires cell lysis and therefore, death, 
particularly in gram negative bacteria that lack a cell wall (Riley & Wertz, 2002b; Riley & 
Chavan, 2006). These negative fitness consequences on both the producer and the target 
competitor classify bacteriocin production as a spiteful trait (Gardner et al., 2004; West et al., 
2007a). Despite such costs, bacteriocin production is ubiquitous, and almost all known lineages 
of bacteria and archaea produce at least one bacteriocin (Klaenhammer, 1988; James et al., 
1991).  
 
 In this dissertation I examine the evolution and maintenance of spiteful bacteriocin 
production, and its association with disease in natural isolates of the insect-pathogenic bacteria 
Xenorhabdus spp. This research is broadly motivated by three questions: 
 
1. How is spiteful bacteriocin production maintained despite being so costly?  
2. Does investment in spiteful bacteriocin production affect host-pathogen relationships?  
3. Can we harness insights from this ubiquitous bacterial trait for disease management?  
 
In the following sections, I summarize the specific contributions my dissertation makes towards 






spiteful bacteriocin production using experiments and modeling. In Chapters 3 and 4, I examine 
how spiteful competition is associated with disease and may influence disease management 
strategies. This work advances a growing body of literature, which demonstrates the importance 
of social interactions in shaping, and being shaped by, evolution in the microbial world. 
 
Chapters 1 and 2 : The evolution and maintenance of spiteful bacteriocin production  
 
The evolution of spiteful behaviors poses an important challenge to evolutionary theory 
(Hamilton, 1970). How can a trait that decreases the fitness of both actors and recipients be 
maintained by selection? I examine this question by studying bacteriocin production, which is a 
premier example of spiteful behavior in nature (West et al., 2007a). Theory and experiments 
suggest that the competitive environment is key for the maintenance of bacteriocin-producing 
lineages (Chao & Levin, 1981; Gardner et al., 2004; Inglis et al., 2009). Specifically, theory 
predicts that resource allocation to bacteriocin production is most favored when the producing 
lineage occurs at intermediate frequencies relative to a competing lineage (Gardner et al., 2004). 
Consistent with this prediction, empirical work with the opportunistic pathogen, Pseudomonas 
aeruginosa, has shown that the relative fitness of a bacteriocin-producing lineage in competition 
with a bacteriocin-sensitive, competitor lineage, is the highest when the starting frequencies of 
the producer and sensitive strains is 1:1 (Inglis et al., 2009). Thus, bacteriocin production is most 
beneficial when producers and competitors occur at comparable frequencies. As such, it is 
reasonable to hypothesize that phenotypically plastic bacteriocin production – in which 
bacteriocins are only released when competitors are present – may be favored by selection. This 






bacteriocin release upon ‘provocation’ by competitors (Majeed et al., 2011; Gonzalez et al., 
2018; Mavridou et al., 2018).  
 
In Chapter 1 of my dissertation, I tested the hypothesis that bacteriocin production is 
phenotypically plastic and upregulated in the presence of non-self competitors in vitro. I 
conducted the work using natural isolates of Xenorhabdus spp. Xenorhabdus spp. are insect-
pathogenic bacteria that have been a premier study system for the study of spiteful bacteriocin 
production in nature, and bacteriocin-mediated interactions are known to occur within the insect-
host (Hawlena et al., 2010a,b; Bashey et al., 2012, 2013). To test whether bacteriocin production 
in these bacteria is induced in response to the presence of non-self competitors, the competitive 
environment of a bacteriocin producing strain (X. koppenhoeffri) was manipulated by growing 
the producer strain either in pure culture or in the presence of equal initial frequencies of a non-
self strain. The competitor strain was derived from the producer’s sympatric, bacteriocin-
sensitive competitor, X bovienii. Bacteriocin extracts were collected at four different time points 
over the course of in vitro growth, and the inhibitory activity of the bacteriocin extracts was 
measured using a quantitative growth inhibition assay. Surprisingly, the results provided no 
evidence for increased bacteriocin production in the presence of the competitor (Bhattacharya et 
al., 2018). Bacteriocin production was detected during late growth stages regardless of the 
competitive environment with no quantitative differences in the inhibitory activity of 
bacteriocins between the treatments. These results were puzzling.  
 
Bacteriocin production and release is widely described in the literature as a ‘suicide 






lysis (Nedelcu et al., 2010; Mitri & Foster, 2013). It is frequently assumed that individual 
producer cells lyse and die for the sole purpose of releasing bacteriocins. If that is true, then the 
results of chapter 1 are even more puzzling. Why would producer cells commit ‘suicide’ to 
release bacteriocins in the absence of competitors? To understand if ‘suicides’ are indeed 
necessary for bacteriocin-mediated competition to be effective, Curt Lively and I developed a 
new model that examines the simplest conditions necessary for costly bacteriocin production to 
be favored. This model is described in Chapter 2 of this dissertation. The model incorporates 
explicit demographic details and investigates the invasion of a rare, bacteriocin-producing 
mutant in a metapopulation dominated by a faster growing sensitive strain. Results demonstrate 
that bacteriocin release by lysis upon natural cell deaths, rather than additional ‘suicidal’ release,  
can be sufficient for a rare producer strain to invade a meta-population of faster-growing 
sensitive competitors. Further, competition-induced, plastic bacteriocin release can promote 
producer-invasion at increasingly global scales of competition, but the benefits of plasticity are 
lost if scale of competition is local. We argue that for pathogens like Xenorhabdus spp.,whose 
dispersal (or transmission) is numerically limited by vectors, the scale of competition is local, 
thus reducing selection for plasticity.  
 
Taken together, these chapters investigate the largely untested role of phenotypic 
plasticity in the maintenance of spiteful bacteriocin production. Model results demonstrate that 
bacteriocins released by natural cell deaths can be sufficient for bacteriocin production to persist 
and that plasticity isn’t necessary for the maintenance of spiteful bacteriocin production. These 
results may call into question whether bacteriocin production is indeed spiteful at the level of the 






under the assumption that the individual producing the bacteriocin sacrifices itself for the 
specific purpose of killing competitors. However, if the individual cells that release bacteriocins 
only do so upon natural death, the trait may not be spiteful in the same way as previously 
thought. Taken together the results of chapters 1 and 2, challenge the commonly made 
assumption that bacteriocin production is a ‘suicide mission’ and offer a new way of thinking 
about the maintenance of costly bacteriocin production 
 
Chapters 3 and 4: Spiteful bacteriocin production and disease 
 
 Increasing evidence suggests that social interactions within pathogenic populations can have 
important consequences on disease (Leggett et al., 2014). Cooperative bacterial traits such as 
biofilm formation and public goods production are directly associated with pathogens’ ability to 
establish in new hosts and influence the degree of damage caused to the host, i.e. virulence 
(Koutsoudis et al., 2006; Köhler et al., 2009; Strateva & Mitov, 2011; Pollitt et al., 2014). 
Within-host competitive interactions also have myriad effects on disease virulence. Increased 
competition for resources may select for faster pathogen growth resulting in increased virulence 
during mixed infections relative to single infections (de Roode et al., 2005). In contrast, spiteful 
competitive interactions during mixed infections can reduce pathogen densities and select for 
reduced virulence (Massey et al., 2004; Vigneux et al., 2008; Inglis et al., 2009). By shaping 
pathogen growth and disease virulence, social traits in pathogens play a central role in pathogen 
evolution (Buckling & Brockhurst, 2008). 
  
In Chapter 3 of this dissertation, I examined the relationship between virulence and 






Theory predicts a negative correlation between virulence and bacteriocin production because 
faster growth is associated with increased virulence, while bacteriocin production is costly and 
reduces pathogen growth (Gardner et al., 2004). Consistent with this theory, experiments have 
shown that spiteful competition during mixed infections can result in reduced virulence (Massey 
et al., 2004; Vigneux et al., 2008; Inglis et al., 2009; Bashey et al., 2011). However, very few 
studies have examined if the evolution of virulence and spite are linked within pathogen 
populations. Garbutt et al. (2011) found that the evolution of Bacillus thuringiensis lineages 
under mixed infections resulted in selection for reduced virulence and increased antagonism. The 
increase in antagonism occurred without evolution of increased growth rates, indicating that the 
antagonism was likely bacteriocin mediated. Nonetheless, whether and how virulence evolution 
affects levels of bacteriocin production is currently unclear. 
 
In Chapter 3, I investigate the evolutionary interplay between virulence, growth, and 
bacteriocin production in Xenorhabdus nematophila populations. Using experimentally evolved 
lineages that show faster host-killing (Morran et al., 2016) and thus, increased virulence, we 
asked whether increased virulence was associated with changes in levels of bacteriocin 
production and growth. Consistent with theoretical predictions, we found a significant decrease 
in bacteriocin production among the more virulent lineages relative to their ancestral population. 
The more virulent lineages also showed faster growth rates relative to their ancestor. Comparing 
the levels of bacteriocin production and growth across all the evolved and ancestral lineages 
revealed a significantly negative correlation, demonstrating the underlying growth costs of 
bacteriocin production. Overall, these results suggest that the evolution of greater virulence in 






bacteriocin production. These results offer some of the earliest insights into how bacteriocin 
production is affected by virulence evolution in pathogenic populations. 
 
Intricate relationships between pathogen social traits and virulence can offer novel 
opportunities for disease management strategies to exploit (Foster, 2005; Brown et al., 2009; 
Allen et al., 2014b). Cooperative traits that can promote virulence are vulnerable to ‘cheating’ by 
mutants that do not invest in the cooperative trait themselves, but can spread through the 
population by exploiting the benefits of costly cooperation (Diggle et al., 2007; Popat et al., 
2012). Using the ability of such ‘social cheats’ to disrupt cooperation in pathogenic populations 
may help reduce pathogen growth and thus, virulence (Sandoz et al., 2007; Harrison et al., 
2017). Similarly, the trade-offs between virulence and spiteful competition as shown in Chapter 
3 and by other studies (Massey et al., 2004; Vigneux et al., 2008; Bashey et al., 2011), suggest 
that maintaining selection for spiteful traits may help reduce virulence. Akin to using ‘social 
cheats’, the use of genetically engineered probiotics as therapeutics (Sola-Oladokun et al., 2017) 
may help keep disease virulence low.  
 
Competitive interactions among pathogens have also emerged as an important factor for 
managing the evolution of antimicrobial resistance (de Roode et al., 2004; Wale et al., 2017), 
which is among the most pressing public health challenges we currently face (World Health 
Organisation, 2018). Exposure to high antimicrobial doses over long durations can eliminate 
sensitive pathogens effectively (Ehlrich, 1913). However, by eliminating conspecific, 
antimicrobial-sensitive competitors, this approach also imposes strong selection favoring highly 






maintain sensitive competitors to constrain the spread of resistant mutants (de Roode et al., 2004; 
Kouyos et al., 2014; Hansen et al., 2017). However, this approach may fail if a healthy host 
cannot tolerate the levels of sensitive pathogens required for competitive suppression of 
resistance to be effective (Hansen et al., 2017). Nonetheless, resource competition between 
conspecific antibiotic-sensitive and antibiotic-resistant mutants can prevent the emergence of 
resistance (Colijn & Cohen, 2015). 
 
There is an urgent need to find alternative antimicrobials to replace conventional 
antibiotics that have been rendered ineffective as a consequence of resistance evolution (Allen et 
al., 2014a). Bacteriocins are a proposed class of alternative antimicrobials because of their 
specific killing activity and ubiquitous production (Reviewed in Cotter et al., 2013). However, to 
avoid a similar fate as antibiotics, it will be necessary to develop sustainable approaches of 
administering alternative antimicrobials like bacteriocins. In Chapter 4, I tested whether the 
principle of competitive suppression of resistance can be harnessed by using heterospecific 
competitors instead of relying on sensitive, conspecific competitors (Bhattacharya et al., 2019). 
In vitro, proof-of-concept experiments were conducted to examine (a) how bacteriocin dose 
affects resistance-evolution in the lab, (b) whether incorporating live, heterospecific competitors 
in conjunction with antimicrobial doses can alter the outcome, and (c) could a bacteriocin-
producing competitor alone be sufficient to achieve low target cell densities and resistance.  
 
Our results show that exposure to a high bacteriocin dose can suppress total densities of 
sensitive cells effectively, but imposes strong selection for resistance. In contrast, resistance 






target cells remain high. Incorporation of a live heterospecific competitor strain in conjunction 
with the bacteriocin dose significantly reduced resistance evolution as well as total cell densities. 
The competitor strain used in the experiment wasn’t sensitive to the bacteriocin used in the 
experiment, and it did not produce antimicrobials that affected the growth of the target strain. 
The combination of low bacteriocin dose and competitor had the lowest total as well as resistant-
cell densities at the end of the experiment. This effectiveness was matched by using a 
bacteriocin-producing competitor directly as opposed to applying extracted bacteriocins in 
conjunction with a bacteriocin non-producing competitor. Taken together these provide strong 
proof-of-concept evidence to suggest that using live, heterospecific competitors in conjunction 
with antimicrobial doses can be an effective therapeutic strategy. For such a therapeutic strategy 
to work, the choice of the competitor strain will be very important. Bacteriocin-mediated 
interactions have been shown to drive the efficacy of many probiotic strains (Su et al., 2007; 
Gillor et al., 2009; Dobson et al., 2012). Ongoing efforts to devise genetically engineered 
probiotic strains (Sola-Oladokun et al., 2017) and harmless commensal bacteria may provide 
suitable candidates for consideration as therapeutic agents for the competitive suppression of 
resistance. 
 
Taken together, Chapters 3 and 4 of my dissertation offer new insights into the intricate 
links between pathogen social traits and pathogen evolution. Our results demonstrate that spiteful 
bacteriocin production is negatively associated with virulence evolution, and show that 
competitive interactions can provide a force to counteract the evolution of antimicrobial 






management strategies and contribute to a rapidly-growing body of work in the field exploring 
exploitable links between pathogen social traits and disease. 
 
To conclude, in this dissertation I investigated the evolution of spiteful bacteriocin 
production and its association with disease in the insect-pathogenic bacteria Xenorhabdus spp. 
My research addresses how such a costly trait can be maintained by selection, whether it is 
directly linked to disease evolution, and if it can offer insights for disease management. I 
examined the largely untested role of phenotypic plasticity in the maintenance of spiteful 
bacteriocin production (Chapters 1-2). Results from experiments and modeling suggest that 
bacteriocin production can be maintained without phenotypic plasticity in response to the 
presence of non-self competitors. Further, bacteriocin release as a consequence of natural cell 
deaths can be sufficient to maintain bacteriocin production. I also investigated the evolutionary 
link between virulence and spite and showed that the evolution of increased virulence is 
associated with reduced levels of bacteriocin production in the insect-pathogenic bacterium, X 
nematophila (Chapter 3). Finally, experiments in Chapter 4 examine the evolution of bacteriocin 
resistance and show that incorporating live, heterospecific comeptitors in conjunction with 
bacteriocin dose can significantly reduce the emergence of bacteriocin resistance in vitro. Taken 
together my dissertation attests to the power of bacterial social interactions to inform academic 
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Abstract  
Anti-competitor traits such as the production of allelopathic toxins can confer significant 
competitive benefits but are often costly to produce. Evolution of these traits may be facilitated 
by environment-specific induction; however, the extent to which costly anti-competitor traits are 
induced by competitors is not well explored. Here, we addressed this question using bacteriocins, 
which are highly specific, proteinaceous anticompetitor toxins, produced by most lineages of 
bacteria and archaea. We tested the prediction that bacteriocin production is phenotypically 
plastic and induced by the presence of competitors by examing bacteriocin production in the 
presence and absence of nonself competitors over the course of growth of a producing strain. Our 
results show that bacteriocin production is detectable only at high cell densities, when 
competition for resources is high. However, the amount of bacteriocin activity was not 
significantly different in the presence vs. the absence of nonself competitors. These results 
suggest that bacteriocin production is either (1) canalized, constitutively produced by a fixed 






specific self/nonself discrimination. Such a non-specific response to competition could be 
favored in the natural environment where competition is ubiquitous.  
 
Introduction  
Competition is one of the most pervasive biological interactions, and it plays a key role in 
structuring ecological communities (Tilman, 1982). Anti-competitor strategies such as the 
production of allelopathic chemicals, can confer a competitive advantage to the producers, but 
such chemicals are often associated with high costs (Riley & Wertz, 2002b; Pintar & Starmer, 
2003; Lankau, 2008). How are such costly competitive strategies maintained? Phenotypic 
plasticity may serve as one important mechanism for the maintenance of costly traits as the costs 
may be mitigated through conditional, environment-specific expression of the traits. For 
example, predator-induced morphological changes allow protection in the presence of a predator, 
but also allow for reduced costs in the absence of predation (Lively, 1986b; Baur et al., 1991; 
Laforsch & Tollrian, 2004). Similarly, costly chemical defenses are well-documented to be 
induced by herbivory (Haukioja, 1991; Dicke & Hilker, 2003; Zangerl, 2003). However, the 
degree to which equally costly anti-competitor chemicals are induced by competition has not 
been well explored. To date, just a few studies have found evidence for competition-induced 
increases in the production of allelopathic compounds in some plants, algae, and bacteria 
(Lankau & Kliebenstein, 2009; Korgaonkar & Whiteley, 2011; Rasher & Hay, 2014).  
 
Despite these examples of adaptive plasticity, not all costly traits will be phenotypically 
plastic. Phenotypically plastic genotypes need to maintain sensory and regulatory machinery 






incur costs relative to non-plastic genotypes (reviewed in DeWitt et al. 1998; Murren et al. 
2015). Other factors such as the timeliness of phenotypic response following environmental 
change, as well as reliability of environmental cues may impose limitations on the benefits 
gained from plasticity (Lively, 1986a; Moran, 1992; Padilla & Adolph, 1996; Scheiner & Holt, 
2012). Further, environmental heterogeneity over relevant time scales for the trait in question is a 
key criterion for the evolution of adaptive plasticity (Bradshaw, 1965; Moran, 1992). Thus, 
whether a costly competitive trait is phenotypically plastic and induced by the presence of a 
competitor is likely to be determined by the interplay of multiple ecological and physiological 
parameters. 
 
Bacteriocins provide an excellent opportunity to investigate whether costly anti-
competitor chemicals are competitor induced. Bacteriocins are a class of allelopathic compounds 
produced by bacteria that can confer a competitive advantage by targeting and killing closely 
related competitors. A vast majority of archaea and almost every known lineage of bacteria are 
known to produce at least one bacteriocin (Klaenhammer, 1988; James et al., eds, 1991; Riley & 
Wertz, 2002a). However, bacteriocin production is highly costly, requiring the lysis of producing 
cells in some species and the costs of production are often greater than the direct benefits gained 
through competitor killing (Riley & Wertz, 2002b; Riley & Chavan, 2006; Wloch-Salamon et 
al., 2008). As such, bacteriocin production is considered one of the clearest examples of spite in 
nature whereby the producers incur a substantial cost and reduce the fitness of targeted 
competitor cells (Gardner et al., 2004; West et al., 2006). Theory predicts that resource 
allocation to bacteriocin production should be increased when the producing lineage occurs at 






work has shown that the relative fitness of a bacteriocin-producing lineage is highest when the 
starting frequencies of the producer and sensitive strains is 50 : 50 (Inglis et al., 2009). 
Therefore, it is reasonable to hypothesize that bacteriocin production is phenotypically plastic 
and increased in more competitive environments. This hypothesis remains largely untested. 
 
The ability to sense appropriate changes in the environment is critical for phenotypic 
plasticity to be adaptive. Bacteria are known to respond to changes in their social environments 
(Kümmerli et al., 2009; Rumbaugh et al., 2009) and communicate with each other through 
diverse mechanisms including quorum sensing (Lerat & Moran, 2004; Waters & Bassler, 2005) 
and contact-dependent interactions (Gibbs et al., 2008; Basler et al., 2013; Ruhe et al., 2013). 
Particularly relevant to bacteriocin production is the recently proposed ‘competition sensing 
hypothesis’ which posits that bacteria have evolved the ability to sense and respond to 
competition (Cornforth & Foster, 2013). A meta-analysis of bacteriocin regulatory pathways 
revealed that production is frequently regulated by stress-response pathways that are triggered by 
competition-related stressors such as nutrient stress and cellular damage. Conversely, bacteriocin 
production is rarely associated with stress response pathways that are sensitive to stressors like 
heat or osmotic stress, which are not competition related (Cornforth & Foster, 2013).  
 
Here, we test whether bacteriocin production plastically increases in more competitive 
environments by examining bacteriocin production at different stages of growth in the presence 
and absence of nonself competitors. We test this prediction using natural isolates of Xenorhabdus 
spp. (Figure 1), which have been a key study system to investigate the maintenance of 






parasitic bacteria that gain entry into an insect host by forming symbioses with 
entomopathogenic nematodes (Martens et al., 2003; Herbert & Goodrich-Blair, 2007; Stock & 
Blair, 2008). Within the insect host, bacteriocin-mediated interactions occur and are known to 
affect the outcome of competition (Bashey et al., 2012, 2013). We use field-collected isolates of 
Xenorhabdus spp., which have a rich, competitive environment in nature where they may 
frequently, but not always, encounter nonself competitors within the insect host.  
 
Materials and Methods 
Experimental Design 
A producer strain was grown alone (pure culture) or in the presence of a nonself competitor 
strain (mixed culture) and bacteriocin production was examined at multiple time points over the 
course of growth (Figure 2). Producer cell densities were measured at each time point examined. 
To measure bacteriocin production, filter-sterilized supernatants from the cultures were used in 
growth-inhibition assays, where the growth trajectory of a sensitive strain was used as a bioassay 
of the amount of bacteriocin in the supernatant. Specifically, the delay in growth of the sensitive 
strain induced by the presence of a bacteriocin extract was used to derive a metric of bacteriocin 
activity (Figure 2). As a negative control, cell-free supernatant from cultures of the competitor 
strain grown alone were run alongside the two producer treatments and were processed similarly 
at each time point during the bacteriocin-production phase of the experiment, as well as during 










The bacteriocin-producing clone used in this study was a natural isolate of Xenorhabdus 
koppenhoeferi (Kop46) which is known to produce a bacteriocin that can suppress the growth of 
a sympatrically isolated clone of Xenorhabdus bovienii (Bov59) (Bashey et al., 2013). The 
competitor strain used in the experiment, Bov59R, was derived in the lab from Bov59. This 
strain was chosen because bacteriocin that is exposed to Bov59R cells maintains its inhibitory 
activity (Supplementary Materials S1). This was key for the current experiment to ensure that the 
inhibitory activity of the bacteriocin released by producing cells in the mixed treatment would 
not be subsequently altered by the presence of competitor cells. The natural isolate Bov59 which 
is sensitive to bacteriocin was used as the detector strain in the growth-inhibition bioassays. 
These strains of X. koppenhoeferi and X. bovienii are morphologically distinct (Figure 1), 
whereby Kop46 colonies appear maroon and Bov59/59R colonies appear blue on NBTA plates 
(nutrient agar supplemented with 0.0025% (w⁄ v) bromothymolblue and 0.004% (w⁄ v) 
triphenyltetrazolium chloride, pH = 8). In addition, Bov59/59R has a higher natural resistance to 
ampicillin than Kop46, thereby enabling further distinction on NBTA plates with 75g mL-1 
ampicillin. All cultures used in the experiment were derived from freezer stocks maintained at -
800 C and streaked onto NBTA plates prior to each replicate. 
 
Bacteriocin Production Treatments  
To initiate each replicate, individual colonies of each strain were picked from freezer streaks and 
inoculated into 5ml LB media (Difco) in 20ml culture tubes. Cultures were grown overnight at 
28oC and then used to inoculate fresh LB broth to establish the three experimental groups. The 






Kop46 and the competitor Bov59R overnight cultures into 5ml LB. The producer alone treatment 
was established by adding 50l of a Kop46 overnight culture and 50l of LB to 5ml LB. 
Similarly, the negative control treatment was established by adding 50l of the competitor 
Bov59R overnight culture and 50l LB into 5ml LB. All culture tubes were incubated with 
shaking (120 rpms) at 28oC.  
 
Bacteriocin extracts were collected at four time points over the course of growth: 4 hours 
(early exponential), 6 hours (mid exponential), 12 hours (late exponential) and 24 hours 
(stationary phase). Cultures tubes were destructively sampled at each time point. A total of 10 
producer and competitor colonies were examined at 24 hours and 6 colonies each were tested at 
the earlier time points. A small aliquot (100l) was taken from each culture tube both 
immediately after setup and just before bacteriocin collection to calculate initial and final cell 
densities and to ensure the absence of contamination. These aliquots were diluted and plated on 
NBTA agar. Plates were incubated at 28oC for 48 hours before colonies were counted. Cell 
density estimates confirmed that initial densities of producer and competitor cells in the mixed 
treatment were within the same order of magnitude (~10^6 c.f.u/ml) and the average frequency of 
producer cells was 0.61+/- 0.04 (mean +/- 1 S.E.M). 
 
Bacteriocin extracts were collected by centrifuging cultures at 1620 G for 5 minutes and 
the supernatant was filtered through 0.45um filters (Acrodisc). This procedure allows the 
proteinaceous bacteriocin to pass through while eliminating any cells in the extract. These 
bacteriocin extracts were stored at 4oC until use in the growth-inhibition assays. Growth- 







The growth-inhibition assay was used to measure and compare the degree of growth inhibition 
induced by the application of bacteriocin extracts to a starting culture of bacteriocin-sensitive 
cells. Each bacteriocin extract was examined on 4 replicate wells in a 100-well plate reader 
(Honeycomb plate, Growth Curves USA). Each well contained a 200l solution of a bacteriocin 
extract and starting cell culture in 1:5 ratio by volume. Varying cell densities of starting cell 
cultures were used (106, 105 or 104 c.f.u/ml) for bacteriocin extracts from different time points. 
The difference between the lag times induced by the negative control and bacteriocin samples 
increases with decreasing starting cell densities of the detector strain, facilitating the detection of 
bacteriocin-mediated inhibition (Supplementary Materials S2). Consequently, lower cell 
densities were used for the earlier time points where bacteriocin concentrations were low to 
facilitate detection of bacteriocin.  
 
Every plate had internal control wells with un-inoculated media to rule out 
contamination. Culture growth in the wells was measured by a Bioscreen plate reader (Growth 
Curves USA) in which the plates were incubated at 28oC with continuous shaking at medium 
amplitude. O.D.600 was recorded every 30 minutes for 24 hours.  
 
Follow-up Growth Rate Analysis 
 To test whether the presence of Bov59R imposes competition on the producer cells, the growth 
rate of producer cells growing in the presence and absence of the competitor was estimated in an 
additional experiment. Paired replicates of the producer alone and mixed treatments were 






hours from each tube. 100ul aliquots were used to make serial dilutions that were plated on 
NBTA plates to estimate cell densities. Growth rate of the producer over 6 and 24 hours was 
estimated for each tube as ln[producer density at final time point / producer density at 0hrs]. 
 
Statistical Analyses 
The optical density measures for each well were used to compute lag times using the software 
program GrowthRates 2.1(Hall et al., 2013). Lag time represents a measure of the delay 
observed before a culture moves into the exponential growth phase. GrowthRates 2.1 calculates 
lag time as the time point at which the extrapolated slope of the exponential phase line (lnOD vs 
time) meets the X-axis. Every well was manually examined for model accuracy in estimating 
lag-time. 
 
The average lag time value of the four wells containing the same bacteriocin extract were 
used to calculate the relative lag time for each extract (Figure 2). The relative lag time induced 
by a given bacteriocin extract was calculated as the ratio of the average lag time value induced 
by the extract and the average lag time value induced by the corresponding negative control 
extract (extracts from competitor strain Bov59R pure cultures, Figure 2). A relative lag time 
value of 1 indicates no deviation from the negative control and relative lag time values 
significantly greater than 1 indicate inhibitory activity.  
 
 Relative lag times for bacteriocin extracted from pure cultures (Kop46 alone) and mixed 
cultures (Kop46 + Bov59R) were compared at each of the four time points. A mixed-model 






fixed effect and ‘colony identity’ and ‘experimental run’ as random effects. Each experimental 
run was performed using one or two colonies of the producer and competitor. 
 
  Colony counts were used to compare the initial and final cell densities of the bacteriocin 
producer cells and to calculate producer growth rate (ln[producer density at final time point / 
producer density at 0hrs]) across treatments. Mixed model analyses of variance were used with 
‘treatment’ (pure or mixed culture) as fixed effect and ‘colony identity’ and ‘experimental run’ 
as random effects.  
 
For the follow-up growth rate analysis experiment, producer growth rates in the presence 
and absence of Bov59R were compared using mixed model analyses of variance with ‘treatment’ 
(pure or mixed culture) as fixed effect and ‘colony identity’ as random effect.  
 
Results 
Bacteriocin extracts were collected from the pure and mixed cultures at four distinct time points 
(4, 6, 12 and 24 hours). Their inhibitory activities were measured by examining the lag time they 
induced in the growth of the sensitive strain. Significant bacteriocin-mediated inhibitory activity 
was detected only at 12 and 24 hours (Figure 3, 95% C.I. do not overlap with 1). No bacteriocin-
mediated inhibition was detectable at the earlier time points (Figure 3, 95% C.I. overlap with 1). 
There was no significant difference between the relative lag times induced by the extracts 
derived from pure cultures and mixed cultures at any of the four time points examined (Figure 3, 
4 hours: F1,10 = 0.06, p =0.81; 6 hours: F1,10 = 0.20, p =0.66; 12 hours: F1,10 = 0.29, p =0.60 and 24 






We examined producer cell densities at the time of bacteriocin extraction to establish that 
bacteriocin activity was not confounded by differences in the total number of producer cells. 
Comparisons of producer cell densities between the pure and mixed cultures were not 
significantly different at any time point (Figure 4, 4 hours: F1,10 = 0.84, p =0.32; 6 hours: F1,10 = 
1.28, p =0.28; 12 hours: F1,10 = 0.39, p =0.54 and 24 hours: F1,18 = 0.30, p =0.59). The density of 
competitor cells was reduced to, or below our detection limit of 105 c.f.u/ml at 4 hours, and 106 
c.f.u/ml at 6, 12 and 24 hours. Comparable producer densities between treatments indicates that 
on a per cell basis, the producer cells did not differ in their bacteriocin production in response to 
the presence of a nonself competitor. Despite the lack of significant differences in producer cell 
densities, comparing the growth rate of the producer strain in pure and mixed cultures revealed 
an 11.6% reduction in producer growth in the mixed treatment at 6 hours; although, this 
difference was not significant (F1,5 = 1.20; p = 0.32). To determine whether this pattern was 
indicative of a difference in the competitive environment experienced by the producer cells, we 
ran 10 additional replicates of the producer alone and in the presence of Bov59R. Growth rates 
were found to be significantly lower in the mixed treatment at 6 hours (Figure 5, F1,5 = 10.95; p = 
0.021). Producer growth rate was reduced by 11.3% in the follow-up experiment, consistent with 
the reduction observed in the initial experiment. The difference in growth rate did not persist to 
24 hours (Figure 5, F1,5 = 1.10; p = 0.34).  
 
Discussion 
Bacteriocins are a class of allelopathic toxins that are ubiquitously produced across microbial 
lineages despite being highly costly (Riley & Wertz, 2002a; Riley & Chavan, 2006; Wloch-






increased when producer cells occur at intermediate frequencies relative to nonself competitor 
cells (Gardner et al., 2004), the degree to which bacteriocin production is phenotypically plastic 
and induced by the presence of nonself competitors remains underexplored. We tested the 
plasticity hypothesis using natural isolates of Xenorhabdus spp., by examining bacteriocin 
production at various time points over the course of growth when producer cells were grown in 
pure culture, or in co-culture with a nonself competitor strain. Our results show that bacteriocin 
production can be detected during the late exponential phase (12 hours) and the stationary phase 
(24 hours), regardless of the presence of nonself competitors. Thus, there is no evidence for 
increased bacteriocin production in the presence and absence of non-self competitors (Figure 2). 
While bacteriocin activity in both treatments reflected an almost 7-fold increase between 12 and 
24 hours, this increase occurred without any concomitant increases in producer cell densities at 
these time points (Figure 3), indicating that bacteriocin production may be increasing on a per 
cell basis between these time points. However, bacteriocin activity detected at each time point in 
these experiments is cumulative and reflects the activity of bacteriocin produced over the entire 
course of growth until time of sampling. Therefore, the increase in bacteriocin production 
between 12 and 24 hours may be also explained solely by the accumulation of bacteriocin 
without invoking a per capita increase in toxin production. Overall, these results provide no 
evidence to suggest that bacteriocin production is increased in response to the presence of 
nonself competitors.  
 
We set out to test the prediction that bacteriocin production increases in co-culture with 
nonself competitors, when the benefits of toxin production can be realized by the producer 






nonself cells if the nonself cells do not impose increased competition on the producers. To 
determine whether the nonself cells used in our experiment imposed increased competition on 
producer cells, we compared the growth rate of the producer strain in the presence and absence 
of the nonself competitors at 6 hours and 24 hours. Results revealed that producer cells had 
significantly reduced growth rates in the mixed culture at 6 hours (Figure 5), indicating that the 
producer cells experienced increased competition due to the presence of Bov59R cells in the 
mixed culture early on in the experiment. Bacteriocin production was examined over the course 
of growth (Figure 3) encompassing time points when the presence of Bov59R imposes increased 
competition on producer cells in co-culture. However, our results did not provide any evidence 
for increased bacteriocin activity in the presence of the nonself competitor at any examined time 
points (Figure 3). 
 
 Bacteriocin production is costly. In addition to costs of protein synthesis and genetic 
maintenance, many species of gram-negative bacteria require producer cells to lyse for 
bacteriocin release (Riley & Wertz, 2002b; Riley & Chavan, 2006; Wloch-Salamon et al., 2008). 
Consequently, only a small proportion of the producer population is actively engaged in 
bacteriocin production and release at a given time. In E. coli, this frequency has been estimated 
to range between 0.5% and 9% by using gfp-reporter strains linked to bacteriocin promoters 
(Mulec et al., 2003; Bayramoglu et al., 2017). While similar estimates for the frequency of cells 
actively producing bacteriocin remain to be determined for the natural isolates of Xenorhabdus 
spp., our functional assays clearly show no evidence in support of the hypothesis that bacteriocin 
production increases in the presence of nonself competitors. Recently published work 






competitors (Mavridou et al., 2018). Intriguingly, the competitor strain used in our experiment 
does not attack the producer strain. This contrast suggests the possibility that plastic increases in 
toxin production may be more likely to occur when producer cells experience direct attack, and 
this hypothesis may be explicitly tested in future investigations.  
 
The time course of bacteriocin production in our results suggests that bacteriocin 
production increases in stationary phase. These results are consistent with previous findings 
using E. coli (Eraso et al., 1996). Taken together, these results suggest that toxin production may 
be triggered by generic cues associated with competition such as nutrient limitation, arising from 
increasing cell densities, instead of specific mechanisms of self/nonself detection. Such a 
mechanism of competition sensing via generic cues is also consistent with the ‘competition 
sensing hypothesis’ (Cornforth & Foster, 2013). The ability of bacterial cells to detect and 
respond to nonself genotypes has been documented in multiple species (Gibbs et al., 2008; 
Garbeva et al., 2011; Korgaonkar & Whiteley, 2011; Unterweger et al., 2012; Basler et al., 2013; 
Wenren et al., 2013). However, tailoring specific responses to different nonself genotypes may 
be highly costly and require specialized receptors to detect specific competitor cues. Moreover, 
competitor cues may also evolve to evade detection. Thus, it has been suggested that sensing 
general cues associated with competition may be more useful than relying on self/nonself 
recognition (Cornforth & Foster, 2013).  
 
An important criterion for a phenotypically plastic response to be effective is its 
timeliness (Padilla & Adolph, 1996). Plasticity in bacteriocin production may be unfavorable if 






competing strain while the producer first detects and then responds by producing bacteriocins. 
The Xenorhabdus spp. isolates used in this study are entomopathogenic bacteria which form 
mutualistic associations with Steinernema nematodes to enter an insect host (Martens et al., 
2003; Stock & Blair, 2008). Quick growth is crucial for the successful colonization of the insect 
host as well as for the competitive success of these bacteria (Bashey et al., 2011). In fact, in 
some cases, a sensitive but faster growing isolate can outcompete a producer strain (Bashey et 
al., 2013) demonstrating the importance of timing in the within-host competitive environment. 
 
Further, if producers frequently encounter sensitive, nonself competitors in their natural 
habitat, selection for plasticity in response to a nonself competitor may not be strong. The 
benefits of bacteriocin production during frequent encounters with sensitive competitors may 
outweigh the costs of toxin production on rare occasions when the producer does not encounter a 
competitor. These conditions seem plausible for the species used in this study. Numerous 
genotypes of Xenorhabdus spp. have been found at an ecologically relevant scale (Hawlena et 
al., 2010a; b) suggesting that the presence of nonself competitors may be ubiquitous in nature, 
thus further reducing the selection for plasticity. Future investigations may employ experimental 
evolution to investigate whether bacteriocin production differentially evolves when competitors 
are reliably encountered in the environment or not.  
 
In highly diverse communities with numerous producing, sensitive, and resistance 
genotypes, bacteriocin production may be maintained through non-transitive interactions 
resulting in frequency-dependent selection (Kerr et al., 2002). Additionally, the prediction that 






hold up if bacteriocins serve other functions in addition to anticompteitor roles. It has been 
suggested that for microbes that form symbioses with other organisms, antimicrobial toxins may 
also serve as honest signals to facilitate mutualist pairing (Hillman & Goodrich-Blair, 2016). If 
bacteriocins serve as important signals to attract nematode mutualists, then production would be 
beneficial and necessary even in the absence of bacterial competitors. If so, once producer 
populations reach high densities, it may be time to find mutualist partners within the host and 
release bacteriocins irrespective of the presence of nonself competitors. Further investigation to 
examine the consequences of manipulating bacteriocin production on effective symbiont 
association could influence the way costs and benefits of bacteriocin production are understood 
and shed light on the regulation and maintenance of bacteriocins in nature. In addition to 
bacteriocins, allelopathic traits in other taxa may also not be plastically responsive to the 
presence of nonself competitors for analogous ecological reasons. Overall, these results strongly 
highlight the need for more studies in the future aimed at investigating the constitutive versus 
inducible nature of anti-competitor traits and testing alternative predictions to develop a better 
understanding of how costly anti-competitor traits are maintained in nature. 
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Figure 1: Image showing colonies of natural Xenorhabdus isolates used in the study. The 
producer strain Xenorhabdus koppenhoeferi isolate 46 (Kop 46), grows as small, maroon 
colonies, while colonies of the competitor strain Xenorhabdus bovienii isolate 59 (Bov 59) are 









Figure 2: Schematic showing the experimental design and methods. The competitive 
environment of a bacteriocin producing lineage was manipulated by either growing the producer 
strain alone in pure culture or in the presence of a competing strain in mixed culture. Bacteriocin 
extracts were collected from these treatments at four different time points (4, 6, 12 and 24 hours). 
These extracts were subsequently tested for inhibitory activity using a growth inhibition assay. A 
fixed amount of a bacteriocin extract was added to a starting culture of bacteriocin sensitive 
cells. The growth of these cultures was tracked in an optical plate reader which measured OD600 
readings at 30 minute intervals for 24 hours. An extract derived from a pure culture of the 
competitor cells which contains no bacteriocin was used as a negative control for the bacteriocin 
extracts. Data from the optical plate reader yields growth curves as shown. Four curves for each 
treatment represent curves from four replicate wells on the optical plate reader. Lagtimes were 
estimated for all wells and the average of four wells for each treatment was used to calculate 








Figure 3: Relative lag times (+/- 95% confidence intervals) induced by bacteriocin extracts 
collected from cultures of the producer growing alone (filled-in circles), and producer growing in 
mixed cultures with equal starting frequencies of a competing strain (empty squares). The X-axis 
represent the time points at which bacteriocin extracts were collected over the course of growth. 
Each time point was destructively sampled. Relative lag time values greater than 1 indicate 










Figure 4: The density (+/- 1. S.E.M.) of cells from the bacteriocin producer strain in the pure and 









Figure 5: The growth rate of the producer strain (+/- 1. S.E.M.) in pure and mixed cultures 
measured at 6 and 24 hours. Growth rate at each time point was calculated as ln[final density of 
producer cells / initial density of producer cells]. The * indicates a significant difference between 









S1: Choosing the competitor strain for mixed treatment – This assay was performed to 
determine whether the inhibitory activity of bacteriocin produced by the producer strain could be 
subsequently affected by the presence of the competitor strain in the mixed culture. To test 
whether exposure to cells can affect the inhibitory activity of bacteriocin, a fixed amount of 
chemically induced bacteriocin was either “Exposed” by applying it to a starting culture of cells 
(Bov59 and Bov59R) or “Unexposed” by adding it to the same volume of un-inoculated growth 
medium (Luria Broth). A pure culture of Bov59R with no added bacteriocin was used as a “No 
Bacteriocin” negative control. All four treatments were incubated at 28oC with shaking for 24 
hours. Following incubation, supernatants were collected and a growth inhibition assay was 
performed to compare the bacteriocin-mediated inhibitory activity across the four groups. Here, 
inhibitory activity is measured as the absolute lagtime (minutes) induced by the various extracts 
on the growth of a starting culture of bacteriocin sensitive Bov59 cells. Absolute lag times 
induced by the no bacteriocin negative control, unexposed bacteriocin and the bacteriocin 
extracts exposed to either Bov59 or Bov59R were compared using a mixed model analysis of 








Figure S1: Inhibitory activity of bacteriocin exposed to Bov59 and Bov59R cells in 
comparison with bacteriocin that is unexposed to any bacterial cells. Bacteriocin that was 
previously exposed to Bov59 cells showed a significant reduction in inhibitory activity compared 
to bacteriocin which was previously unexposed to cells but otherwise similarly treated. In 
contrast, exposure to the lab-derived Bov59R strain showed the same inhibitory activity of 
bacteriocin as unexposed bacteriocin. Following these results the Bov59R strain was chosen as 
the competitor strain for the mixed treatment. Mean lagtime (+/- Standard error ) are plotted in 







S2:  Sensitivity of the growth inhibition assay – The growth inhibition assay was performed 
using three different starting cell densities (10^6, 10^5 and 10^4 c.f.u/ml) of the sensitive detector 
culture. Three different dilutions of chemically induced bacteriocin were applied to starting 
cultures at each density. A no bacteriocin negative control was applied to each starting cell 
density as well. The difference in lagtimes induced by a bacteriocin dilution and the respective 
negative control was used as a metric of assay sensitivity. A greater difference in the induced 
lagtimes between negative control and bacteriocin samples provides an increased window for 
detecting bacteriocin activity.  Each bacteriocin dilution- x- cell density combination was tested 
on four replicate wells in the optical plate reader. The induced lagtime for each well was 
subtracted from the mean induced lagtime of the relevant no bacteriocin control. The average 
differences in induced lagtimes with respective standard error of means  are plotted in Figure S2.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
 
 
Figure S2: Sensitivity of growth inhibition assay increases with decreasing starting cell 






negative control and the lagtime induced by a fixed concentration of chemically induced 
bacteriocin increases when growth inhibition assay is performed using lower starting cell culture 
densities. Shown here are three different dilutions of chemically induced bacteriocin (100-fold, 
1000-fold and 10000-fold) tested across three different starting cell densities. For any bacteriocin 
dilution, the difference in lagtimes between negative control and bacteriocin dilution is highest at 
the lowest starting cell dilution. This increased difference in the lagtimes makes it more likely to 
detect inhibitory effects of low concentrations of bacteriocins. The error bars represent standard 










The evolution of spiteful bacteriocin production 
                                            A. Bhattacharya and C. M. Lively 
 
Abstract 
 A premier example of spite in nature is the bacterial production of anti-competitor toxins, called 
bacteriocins, which can kill closely related competitors. The synthesis of these toxins is 
considered spiteful due to their high costs of production. In addition, the release of bacteriocins 
is often considered a ‘suicide mission,’ as many species require cell lysis to expel their toxins. 
Despite such costs, bacteriocin production is ubiquitous in bacteria. How did such a costly 
strategy become so common?  Here, we used a modeling approach to investigate the invasion of 
a rare, toxin-producing mutant in a population dominated by a faster-growing sensitive strain. 
First, we examined local competition between a bacteriocin-producing mutant and a bacteriocin-
sensitive strain within a focal resource patch. Our results showed that bacteriocin release upon 
natural cell death can be sufficient for the bacteriocin producer to outcompete a faster growing 
sensitive competitor within the focal patch. Next, we examined whether the bacteriocin-
producing mutant could invade the larger metapopulation composed of non-focal resource 
patches colonized by the sensitive strain. We found that bacteriocin production can invade a 
metapopulation when the scale of competition is partially local. Further, we found that plastic 
bacteriocin release via inducible cell deaths (suicides) in response to the presence of sensitive 






the relevance of these results for natural populations, and present a specific example of canalized 




The evolution and maintenance of spiteful behaviors that reduce the fitness of both the actor and 
the recipient pose a long-standing evolutionary puzzle (Hamilton, 1964, 1970). How can a trait 
that reduces the fitness of the actors and the recipients be favored by natural selection?  One of 
the clearest examples of spite in nature is the production of anti-competitor toxins by bacteria, 
known as bacteriocins (Riley & Chavan, 2006; West et al., 2007a). Bacteriocins are 
proteinaceous toxins with diverse mechanisms of action, which can kill closely related local 
competitors without killing clone mates (Reeves, 1965; Riley & Chavan, 2006). However, the 
costs of toxin synthesis often result in slower growth of the producing strains, rendering the trait 
spiteful (West et al., 2007). In addition, the release of these large, proteinaceous toxins often 
requires cell lysis, particularly in gram-negative cells, which lack a cell wall (Riley and Wertz 
2002; Riley and Chavan 2006). As such, discussions of bacteriocin production in the literature 
often assume that bacteriocin release is a product of additional cell death ('suicide') for the sole 
purpose of bacteriocin release, thus imposing extremely high direct costs of production on 
individual producer cells (e.g., Nedelcu et al., 2010; Mitri & Foster, 2013). Despite being costly, 
bacteriocin production is ubiquitous in bacteria (Klaenhammer, 1988; James et al., 1991).  
 
Previous work suggests that the competitive environment maybe an important factor in 
the evolution of bacteriocin production (Chao & Levin, 1981; Gardner et al., 2004). Using a 
game theoretical approach, Gardner et al. (2004) showed that the optimal level of resource 






model predicts that relatively high investment in bacteriocin production is favored under 
intermediate relatedness. Additionally, models suggest that spite is more likely to be favored 
under local competition than global competition (Gardner & West, 2004; Gardner et al., 2004). 
Consistent with these predictions, experimental work has shown that the relative fitness of a 
bacteriocin-producing Pseudomonas aeruginosa lineage is highest relative to a non-producing 
mutant at intermediate relatedness in local competition with a sensitive competitor (Inglis et al., 
2009, 2011).  
 
The theory and experiments discussed above suggest that investment in bacteriocin 
production is most favored when producers and competitors occur at comparable frequencies 
(Gardner et al., 2004; Inglis et al., 2009). As such, it is reasonable to hypothesize that 
phenotypically plastic bacteriocin production – in which bacteriocins are released when 
competitors are present – may be favored by selection. A recent meta-analysis led to the 
proposition of the ‘competition sensing hypothesis’ which posits that bacterial lineages may have 
evolved to preferentially respond to competition-associated stressors such as cellular damage and 
starvation, by triggering bacteriocin production (Cornforth & Foster, 2013). However, there have 
been few direct empirical tests of plasticity in bacteriocin production and their results remain 
equivocal. Bacteriocin release following ‘provocation’ or toxin-mediated killing has been 
documented in E. coli strains (Majeed et al., 2011, 2013; Gonzalez et al., 2018). Similarly, a 
recent study showed that E. coli producer colonies increased production of bacteriocins when 
neighboring colonies of competitors invaded spatially structured environments (Mavridou et al., 
2018). In contrast, a study of the insect-pathogenic bacteria, Xenorhabdus spp. found no 






(Bhattacharya et al., 2018). In vitro studies in E. coli as well as Xenorhabdus spp. have detected 
bacteriocin production in the absence of competitors during late growth stages of laboratory 
batch cultures (Eraso et al., 1996; Bhattacharya et al., 2018). This may be consistent with the 
‘competition sensing hypothesis’ (Cornforth & Foster, 2013), whereby starvation caused by 
resource depletion triggers bacteriocin production. But if cell lysis is required for bacteriocin 
release, it is puzzling to imagine why cells would commit ‘suicide’ in the absence of 
competitors. In the current study we explicitly investigate whether such plasticity is necessary for 
the invasion of bacteriocin production and examine the conditions that could favor the evolution 
of plasticity in bacteriocin production. 
 
Here we use a modeling approach to examine the simplest conditions for a rare, 
bacteriocin-producing mutant to invade a metapopulation composed of numerous resource 
patches colonized by a faster-growing, sensitive strain. To simplify the model, we assume that 
each new patch is colonized by a fixed, initial number of bacterial cells. In the metapopulation, 
every resource patch is colonized by the sensitive strain except one patch which we the ‘focal 
patch’. In the ‘focal’ patch half of the colonizing cells belong to a bacteriocin-producing mutant, 
and the other half belong to the resident, sensitive strain. We first investigate the conditions that 
would be necessary for the producing lineage to ‘win’ against the sensitive competitor in this 
focal patch. To do this, we develop a resource-based model that incorporates explicit 
demographic details about population growth, and bacteriocin potency. Importantly, we assume 
that bacteriocin production imposes a cost on producer births, and requires cell lysis for release. 
We then investigate the conditions necessary for this bacteriocin-producing strain to invade the 






results show that bacteriocin release by lysis upon natural cell death is sufficient for bacteriocin 
producers to spread. We also examine competitor-induced plasticity in bacteriocin release; we 
find that plastic bacteriocin release can promote the invasion of bacteriocin producers under 




Imagine a metapopulation comprising a large number of resource patches. Each new patch 
contains a fixed amount of resources and is initially colonized by a fixed number of bacterial 
cells. Every colonized patch except one is colonized by a resident strain that does not produce 
bacteriocins. The remaining colonized patch, which we call the ‘focal’ patch (following Frank, 
1998), is colonized by a bacteriocin-producing mutant and the resident strain in equal 
frequencies. The bacteriocin produced by the mutant strain can kill cells of the resident, sensitive 
strain. However, the sensitive strains grow faster because bacteriocin-producing mutant pays a 
growth cost of bacteriocin production. We examine the simplest conditions that would be 
necessary for this bacteriocin producing strain to (a) outcompete the sensitive strain within the 
focal patch and (b) invade and spread through the metapopulation under varying levels of within 
vs. between patch competition.  
 
Our model differs from previous formulations used to investigate the maintenance of 
bacteriocin production in a few ways. Previous models have derived the optimal investment in 
bacteriocin production (Gardner et al., 2004), assuming competition between two or more 






fate of a rare mutation that causes bacteriocin production in a population of sensitive individuals 
that do not produce toxins (but see also Durrett & Levin, 1997). Our model also defines the 
resource environment and assumes that every resource patch has a limited amount of resources. 
Finally, our model includes explicit demographic details like values for birth and death rates of 
the competing strains, allowing us to examine mechanisms that could not be addressed by 
previous models. Specifically, we examine: (a) whether bacteriocin-release upon natural cell 
deaths is sufficient for the invasion of bacteriocin production , (b) whether phenotypically plastic 
‘suicides’ in the presence of competitors can affect the evolution of bacteriocin production, and 
(c) how the timing of dispersal with respect to resource availability affects invasion of 
bacteriocin production. Note that for the case of pathogenic bacteria, dispersal to a new patch can 
be viewed as transmission to a new host.  
 
Within-Patch Competition 
 We began by modeling resource competition between the bacteriocin producer, P, and a 
sensitive resident, S, within the focal patch. The producer strain pays a growth cost of bacteriocin 
production and bacteriocin release required cell death. However, no additional cell death was 
invoked for the specific purpose of bacteriocin release. Our model made the following 
assumptions: 
Producer and Sensitive lineages have equal founder population sizes in the focal patch 
The intrinsic death rate, d, is equal for both lineages 
The birth rate, B, and death rate, D, are both density-dependent 
Producer births is equal to Sensitive births minus the cost of bacteriocin production  






Bacteriocins require cell lysis for release  
  Table 1 describes the terms used in the model. 
 
The amount of available resources, R, was fixed and not replenished. We chose this 
resource structure to represent common, ephemeral habitats in nature. All natural cell deaths 
occurred only after resources were exhausted. Density-dependent birth (Bt) and death (Dt) rates, 
the total numbers of producer (Pt) and sensitive cells (St), and the number of resource units (Rt) 
were computed at every time step, t, for ‘T’ time steps. We assumed that the birth of a new cell 
required one resource unit. Intrinsic birth rate, b, was fixed at 1 which means that the population 
could double its size at every time step if no deaths occurred.  
 
The birth rate, Bt, was density-dependent and declined with increasing density. Bt was 
calculated as: 
  𝐵𝑡 = 𝑏 [1 − 
𝑁𝑡
𝑁𝑡+𝑅𝑡
]        (Eqn 1) 
where ‘b’ is the intrinsic birth rate, and Nt is the total number of cells (Nt = Pt + St).  
 
Similarly, the death rate, Dt, for natural cell deaths was also density-dependent and calculated as: 
  𝐷𝑡 = 𝑑 [
𝑁𝑡
𝑁𝑡+𝑅𝑡
]        (Eqn 2) 
where d is the intrinsic death rate. As described below, this death rate was applied to population 
growth equations only after resources were depleted. The model kept track of the amount of 
resources left in the system and  𝐷𝑡 was set to 0 until resources were depleted. 
 






 𝑃𝑡+1 = 𝑃𝑡[1 + 𝐵𝑡(1 − 𝑥) − 𝐷𝑡]     (Eqn 3) 
 
where x is the selection coefficient against represents the birth-rate cost of bacteriocin 
production. Similarly, the number of sensitive cells entering the next time step was calculated as: 
 𝑆𝑡+1 = 𝑆𝑡[1 + 𝐵𝑡 − 𝐷𝑡 − 𝐷𝑡𝑃𝑡𝑆𝑘𝑖𝑙𝑙𝑒𝑑]    (Eqn 4) 
 
where Skilled was the number of sensitive cells killed by bacteriocins released from the death of 
one producer cell.  
 At every time step, the amount of resources remaining in the system were calculated by 
deducting the number of new producer and sensitive births in that time step from the resources 
available prior to those births:   
 Rt+1 = Rt - PtBt(1 - x) - StBt            (Eqn 5) 
 
When the number of resource units remaining in the system was insufficient for any more births 
to occur (Rt < 1), ‘StationaryPhase’ began. The ‘stationary phase’ was included to mimic the 
growth phase commonly observed during in vitro bacterial growth in cultures when there are no 
new births or deaths. As this point the counter variable began counting time steps for stationary 
phase. In the present model, when the counter reached a value of 6, natural deaths begin to 
occur. The model used conditional ‘if-then’ statements to set the death rate 𝐷𝑡 as 0 in the 
equations before counter reached the chosen value and applied Eqn 2 to calculate 𝐷𝑡 after 
counter reached the chosen number of generations. Note that all results were qualitatively robust 







Invasion of the metapopulation 
 
The within-patch model examines the invasion of a rare, bacteriocin-producing mutant which 
was present only in the ‘focal patch’. For bacteriocin production to succeed as a strategy, this 
rare strain must spread through the entire metapopulation of faster-growing, sensitive strains. 
The likelihood of the producer strain invading the metapopulation may depend on the relative 
importance of within-patch versus between-patch competition, also known as the ‘scale of 
competition’ (Frank, 1998 (pp. 114–133); Gardner & West, 2004; Lively, 2009). We calculated 
the relative fitness of the bacteriocin-producing strain across various scales of competition, a, 
ranging from strictly local competition (a =1) to strictly global competition (a = 0). Strictly local 
competition (a = 1) can be imagined as a scenario in which there is only a single resource patch. 
On the other hand, global competition (a = 0) represents a scenario where the producer strain’s 
relative fitness is determined by its production of daughter cells relative to average production of 
daughter cells by sensitive strains in the non-focal patches. Intermediate values of the scale of 
competition describe the relative importance of local vs global competition. In nature, the scale 
of competition may be determined by various mechanisms including spatial structure, viscosity, 
or mechanisms of dispersal. Regardless of the specific mechanism, we investigated how the scale 
of competition affects whether bacteriocin-production, as a strategy, can invade a 
metapopulation of non-producing, sensitive strains. 
 











where, 𝑊𝑝𝑟𝑜𝑑 is the number of producer cells (Pt) at dispersal in the focal patch; ?̅?𝑙𝑜𝑐𝑎𝑙  is the 
average number of cells per strain in the focal patch at dispersal, i.e., (Pt + St )/2; and ?̅?𝑔𝑙𝑜𝑏𝑎𝑙 is 
the average number of cells per strain in the non-focal patches at dispersal, i.e., Stot/2, where Stot 
is the total number of sensitive bacteria in an average non-focal patch at dispersal. Note that for 
consistency across patches we assume there are two ‘sensitive’ strains in the non-focal patches 
(hence, Stot/2), just like there are a total of two strains (one producer and one sensitive) in the 
focal patch. This is also reflected in the total number of bacterial cells that are present in the 
focal and non-focal patches. The non-focal patches have twice as many sensitive cells to begin 
with as the focal patch.  
The relative fitness of the producer strain, wprod, was examined at two different time 
points representing dispersal: one before resources are exhausted (Generation 20) and another 
after resources have been exhausted (Generation 40).   
 
Competitor-induced plasticity in bacteriocin release 
Finally, we examined whether phenotypically plastic bacteriocin release by the producers would 
be favored by selection. Since bacteriocin release requires cell lysis and death, plastic bacteriocin 
release would result in additional cell deaths beyond natural cell deaths. Thus, to examine 
competitor-induced plasticity in bacteriocin release, the within-patch competition model was 
modified to include additional death rate, z. Specifically, the additional producer deaths due to 




       (Eqn 7).  
Note that according to this formulation, plastic producer-cell deaths depend on both the 






been implicated in predictions about competition sensing (Cornforth & Foster, 2013). However, 
qualitative results in the model are robust to formulations that examine only sensitive strain 
frequency, or only total density.  
 
Plastic deaths were incorporated from the beginning of growth until ‘stationary phase’ ended. 
After stationary phase ends, all deaths are calculated as natural cell deaths, according to the 
intrinsic death rate. This was incorporated to the model by modifying the Eqn 3 to include an 
additional death term for plastic deaths as follows: 
𝑃𝑡+1 = 𝑃𝑡 [1 + 𝐵𝑡(1 − 𝑥) − 𝐷𝑡 −
𝑧𝑆𝑡
𝑁𝑡+𝑅𝑡
 ]     (Eqn 8) 
 
When z = 0,  or if sensitive cells, S, are eliminated from the population, the producer does not 
incur any inducible cell deaths. Invasion of the metapopulation was evaluated as described 
above.  
 
The case of frequency-dependent dispersal 
 
Here we use the model to examine the invasion dynamics of the bacteriocin-producing lineage 
when dispersal is frequency dependent. To do so, we imposed a limit on the total number of 
bacterial cells that can disperse from any given resource patch. For simplicity we set this limit to 
the initial number of cells that colonized new resource patches. The number of producer cells 
that disperse from the focal patch and contribute to the producer’s relative fitness was 






number of sensitive cells that dispersed from the non-focal patches were determined by the 





 We found that a bacteriocin-producing strain cannot outcompete sensitive cells if the bacteriocin 
does not kill any competitors (Skilled = 0), reflecting the cost of bacteriocin production (Figures 
1a,b). However, when bacteriocin production results in a 5% reduction in fitness (x = 0.05), an 
average value of Skilled = 0.5 was sufficient for the producing lineage to outcompete the sensitive 
lineage (Figures 1 c, e, g). At x = 0.1, the producer population was able to outcompete sensitive 
cells at Skilled values of 1 or more (Figures 1 f, h). Greater bacteriocin potency (Skilled) allowed 
producers to overtake sensitive cells faster. Across both levels of costs (x), as the potency of the 
bacteriocin (Skilled) increased, the number of time steps required by the producers to outcompete 
the sensitive cells decreased. It is important to note that in all cases where the producer ‘won’, it 
was only able to do so after resources were depleted and natural cell deaths began. 
 
Invasion of the metapopulation 
 
The results of the within-patch competition showed that a bacteriocin-producing strain could 
outcompete a faster-growing sensitive competitor after resources were depleted. Next we 
examined if the producer strain could invade a metapopulation of sensitive competitors. Here, we 






10 (Figure 1h) . We examined whether the producer could invade when dispersal occurred before 
(Generation 20) and after (Generation 40) resources were depleted (Figure 2a). This specific case 
(Figure 1h) was chosen for simplicity but the analysis could be performed at any fixed values of 
x and Skilled (Figure 1 c-g) by choosing specific dispersal times before and after resources are 
depleted under those conditions. Our results showed that the bacteriocin producer could invade 
the metapopulation of sensitive competitors if dispersal occurred after resources were depleted 
(Figure 2b). However, some degree of local competition was necessary for producers to invade; 
producers failed to invade when the scale of competition was less than 0.3 (Figure 2b).  
 
Competitor-induced plasticity in bacteriocin release 
 
We examined whether and how incorporating phenotypic plasticity in the release of bacteriocins 
affected the competitive outcome within the focal patch and the invasion of producers through 
the metapopulations. Inducible cell deaths are determined by the plastic death rate parameter, z, 
as well as the density and frequency of sensitive competitors (Eqn 2).  
Results showed that increasing inducible cell deaths allowed the producer strain to 
outcompete the sensitive strain faster during within-patch competition (Figures 3 b,c). 
Incorporating inducible deaths also promoted the invasion of the producer strain by allowing the 
producer strain to invade across a greater range of scale of competition values including highly 
global scales of competition where the producers couldn’t invade without plasticity (Figure 3 
e,f). However, the increase in Wprod due to plasticity decreased with increasing local 
competition indicating that plasticity becomes less beneficial at increasingly local scales of 






before resources were depleted (Figure 3 e,f ; Generation 20), which wasn’t possible without 
plasticity (Figure 2 d-f; Generation 20).  
 
The case of frequency-dependent dispersal 
 
We examined how the invasion of the bacteriocin-producing lineage could be affected if 
dispersal was assumed to be frequency dependent instead of density dependent. Results show 
that under frequency-dependent dispersal, the producer population can invade across all scales of 
competition without plasticity (Figure 4). Further, the relative fitness of the producer is at its 
maximum possible value across all scales of competition, eliminating the possibility for 
plasticity to benefit the invasion of producers.  
 
Discussion 
Almost all known lineages of bacteria exhibit a spiteful trait, bacteriocin production 
(Klaenhammer, 1988; James et al., 1991; Riley & Wertz, 2002). Bacteriocins are proteinaceous 
anti-competitor toxins that can kill closely related strains without killing clone mates, but incur 
growth costs of bacteriocin production rendering the trait spiteful (Riley & Chavan, 2006; West 
et al., 2007a). Our goal here was to mechanistically examine how such a costly trait could spread 
when first introduced into a population of faster-growing sensitive cells. To investigate this 
question, we used an invasion analysis in a metapopulation framework. First, we examined 
competition between a bacteriocin-producer and a sensitive strain within a single resource patch. 
Next, we examined the conditions required for a rare producer strain to invade and spread 
through a metapopulation of sensitive strains. Finally, we asked if and how phenotypically 






bacteriocin production in the metapopulation. Our results suggest that bacteriocin release upon 
natural cell death can be sufficient to outcompete sensitive competitors within a patch and invade 
a metapopulation of sensitive strains. Producer invasion depended on the timing of dispersal and 
scale of competition. Competition-induced cell deaths for bacteriocin release extend the 
conditions under which producers can invade but such plasticity is not necessary for successful 
invasion and spread of bacteriocin producers through the metapopulation. 
It is important to note that the model presented here makes conservative assumptions 
about the costs of bacteriocin production and the potency of bacteriocins. The costs of 
bacteriocin production assumed in the model impose a 5% or 10% reduction in births, which is 
fairly steep. It has been previously argued that the fitness costs of bacteriocin production may be 
much less steep than commonly assumed in models (Dykes & Hastings, 1997). Our model 
examines values of bacteriocin potency as low as 0.5, which implies that the death of every 
producer cell results in the bacteriocin-mediated killing of 0.5 sensitive cells, on average. These 
values are highly conservative in the light of empirical estimates in E.coli, which show that every 
lysing producer cell is capable of releasing bacteriocin particles on the order of thousands of 
particles (Gordon & Riley, 1999).  
 
Many bacteria, particularly gram-negative strains, require cell lysis and death for the 
release of bacteriocins (Riley and Wertz 2002; Riley and Chavan 2006). As such, many verbal 
models and discussions often deem bacteriocin production a ‘suicide mission’ whereby producer 
cells incur additional cell deaths for bacteriocin release (eg: West et al., 2007; Nedelcu et al., 
2010). However, whether such ‘suicides’ are necessary for bacteriocin production to be 






showed that bacteriocin release by natural cell death may suffice to confer a competitive 
advantage to the bacteriocin producer within a patch, and allowed the strain to invade a 
metapopulation of sensitive competitors (Figure 2). However, the timing of dispersal and the 
scale of competition were important determinants of the producer strain’s invasion success. We 
examined the invasion success of the producer strain at two distinct time points: one before and 
one after the resources are exhausted (Figure 2a). Results suggested that the producer strain 
could invade if dispersal occurred after resources were depleted, but not before (Figure 2b). Our 
model doesn’t explicitly track whether the producer genotype spreads to fixation when it can 
invade the metapopulation. However, the outcome of within-patch competition suggests that a 
rare, sensitive mutant would be unable to invade a metapopulation of producers under the same 
conditions, implying that an invading producer strain would spread to fixation over time. 
Consistent with previous work on the scale of competition (Durrett & Levin, 1997; Gardner & 
West, 2004; Gardner et al., 2004), our results show that increasing local competition can favor 
the invasion of bacteriocin production (Figure 2b). Overall, the analyses of within-patch 
competition as well as producer invasion suggest that ‘suicides’ may not be necessary for 
bacteriocin production to be maintained. 
 
Despite not being necessary, would phenotypically plastic, inducible cell deaths for 
bacteriocin release benefit the producer strain? We examined this by incorporating additional cell 
deaths that were determined by a plastic death rate parameter, z, that depended on the density as 
well as frequency of the competitor strains (Eqn 8). The formulation of these inducible deaths 
was also inversely proportional to the total resources available, which would be consistent with 






induced by starvation stress (Cornforth & Foster, 2013). Our results showed that phenotypically 
plastic, inducible cell deaths in the presence of competitors could benefit the producer strain by 
allowing it to eliminate sensitive competitors faster within the focal patch (Figure 3 a-c). Faster 
elimination of the sensitive strain allowed the producer to invade the metapopulation even if 
competition was strictly global, or dispersal occurred before resources were depleted (Figure 3f). 
However, the benefits of plasticity depended on scale of competition. The advantage of plasticity 
became less dramatic as the scale of competition became more local. Regardless of inducibility, 
the producer strain achieved maximum relative fitness under strictly local competition (see 
Generation 40, Figure 3 d-f). These results indicate that biological details that can alter the scale 
of competition such as spatial structure or viscosity may affect whether plasticity in bacteriocin 
production will be favored or not. However, plastic bacteriocin release is not necessary for the 
invasion and spread of bacteriocin producers. 
 
The current model can be applied to many bacterial systems that grow on resource-
limited habitats and require cell lysis for bacteriocin release, especially bacterial pathogens. 
Here, we describe a specific example of a bacterial pathogen that has also been a key system for 
the study of bacteriocin production in natural populations, Xenorhabdus spp.(Hawlena et al., 
2010, 2012; Bashey et al., 2012). Xenorhabdus spp. form mutualistic associations with 
Steinernema nematodes to gain entry into their insect hosts (Martens et al., 2003; Herbert & 
Goodrich-Blair, 2007; Stock & Blair, 2008). Within the insect, the nematode and bacteria 
separate, reproduce, and kill the insect host (Burman, 1982; Dunphy & Webster, 1988). 
Bacteriocin-mediated interactions between co-infecting Xenorhabdus strains are known to occur 






release of bacteriocins in Xenorhabdus (Thaler et al., 1995). When host resources are depleted, 
the bacteria must re-associate with their nematode vectors for transmission to a new host 
(Burman 1982, Dunphy and Webster 1988) and just a few bacterial cells are sufficient to pair 
with a single nematode host (Martens et al., 2003)  Thus, dispersal only occurs after resources 
have been depleted akin to the conditions explored in our model results. However, nematode-
mediated transmission between hosts is likely to impose frequency-dependent selection on the 
bacterial pathogens inside the host carcass.  
 
We used our model to examine how transmission by nematode vectors would affect the 
invasion of Xenorhabdus bacteriocin producers. As mentioned before, each nematode host 
associates with only a few bacterial cells for transmission (Martens et al., 2003). As such, 
regardless of the total density of bacteria, the transmission of bacterial strains to new hosts 
depends on their relative frequencies within the host. In order to capture nematode-limited 
dispersal of bacteria from the hosts (i.e., resource patches) in our model, we imposed a limit on 
the total number of bacterial cells that could disperse from each resource patch and the 
transmission of producers and sensitive from the focal patch was thus frequency dependent.. For 
simplicity and consistency, we set this limit on number of cells that can disperse to the initial 
number of cells that colonized a new resource patch in the model. Examining the invasion of 
bacteriocin producers under these conditions showed that any differences in the scale of 
competition were effectively lost when dispersal was frequency dependent, rather than density 
dependent (Figure 4). This result stems from the fact that between-group competition is 
eliminated when there is a limit on the number of dispersing bacteria. Under such circumstances, 






because under strictly local competition (a = 1) and late dispersal, the producer achieved its 
maximum relative fitness with or without inducible deaths (see Figure 3 d-f; Generation 40). As 
such, our model predicts that for a system like Xenorhabdus spp, bacteriocin release upon natural 
cell deaths after resources are depleted should be sufficient for bacteriocin production to invade. 
Consistent with these model results, a recent study found that bacteriocins were only detectable 
in liquid cultures of Xenorhabdus kopenhoefferi during and after the stationary phase when 
resources had run out (Bhattacharya et al., 2018). Further, the presence of a non-self competitor 
did not alter the amount of bacteriocin detected, suggesting the lack of non-self competitor 
induced bacteriocin release. Although the example discussed here is that of a specific symbiont-
pathogen, it is likely that the general assumptions of our model can be applied to other virulent 
bacterial pathogens as well, where transmission occurs in a frequency-dependent manner after 
host resources are depleted.  
 
To summarize, the model suggests that bacteriocin release by natural cell death may be 
sufficient to confer a competitive advantage and allow a rare bacteriocin-producing lineage to 
invade and spread through a metapopulation of sensitive non-producing lineages. Invoking 
plastic bacteriocin release in the presence of competitors may promote the invasion and spread of 
bacteriocin producers, but is not necessary for the spread of bacteriocin production. Relevant 
details about life history, dispersal, and scale of competition can influence specific outcomes and 
the model described here can be used for making and testing specific predictions across a wide 
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Term Description Value 
T Total time steps in addition to time step 0th 100 
t Current time step (range: 1 to T) varies 
b Intrinsic birth rate of producer and sensitive populations 1 
d Intrinsic death rate of producer and sensitive populations 0.1 
x Selection coefficient for the cost of bacteriocin production varies 
Skilled Number of sensitives killed by bacteriocins released from 
each producer death 
varies 
Pt The number of producer cells at time step i P0 = 100 
St The number of sensitive cells at time step i S0 =100 
Nt Nt = Pt + St; total number of cells  
Rt Resource units at time step ‘t’ 
Production of a cell requires one unit 




This variable keeps track of the number of time steps after  






Number of time steps after R< 1 until mortality begins 5 







TotSenDeathst Total sensitive cell deaths during time step t Initiates at 
0 
TotDeathst TotProdDeathst + TotSenDeathst Initiates at 
0 
Dt Death rate  
Bt Birth rate  
TotResInSystemt Total resources in the system; Nt + Rt  

















Figure 1: Model results for ‘Within-Patch Competition’ showing the growth of a bacteriocin-
producing lineage (Producer, solid lines) and a bacteriocin-sensitive, competitor lineage 
(Sensitive, dashed lines) across varying levels of cost of bacteriocin production (x), and 
bacteriocin potency (Skilled). The model assumes that resources are finite and non-replenishable, 
and that all cell death only occurs after stationary phase when resources are depleted. The 
sensitive lineage can outcompete the producer lineage that pays a cost of bacteriocin production 
if Skilled = 0 i.e. when the bacteriocin cannot kill any cells (a, b). At Skilled values as low as 0.5 (c, 
d), i.e. when every producer cell death results in the death of 0.5 sensitive cells on average, the 
producer lineage can overtake the sensitive lineage (c, d). The time taken for the producer 
lineage to outcompete the sensitive lineage after stationary phase decreases as the potency of 
bacteriocin (Skilled) increases. Producer lineages can outcompete the sensitive lineage faster when 










Figure 2: Model results showing within-patch competition (a) and invasion of producer through 
the metapopulation (b), when cost of bacteriocin production x = 0.1, and Skilled = 10. The black 
and grey bars in (a) represent dispersal times examined for invasion. The black and grey lines in 
(b) represent the relative fitness of the producer strain (wprod) across varying levels of scale of 
competition, ‘a’, ranging from completely global (a = 0) to completely local (a =1). The dotted 
line in (b) represents the threshold wprod value required for successful invasion which is 1. As 
seen in (b) the producer strain can invade the metapopulation if dispersal occurs after resources 
have been depleted (Dispersal at Generation 40) and there is some degree of local competition (a 









Figure 3: Model results examining within-patch competition (a-c) and invasion through the 
metapopulation (d-f) at varying levels of inducible deaths (z = 0, 0.1, and 0.2). Axes are the same 
as described in Figure 2. This model examines the consequences of phenotypically plastic 
bacteriocin release determined by the density and frequency of sensitive competitors in the focal 
patch. For all panels shown, x = 0.1, and Skilled = 10. Results suggest that incorporating plastic 
bacteriocin release can allow the producer strain to outcompete the sensitive strain faster (b, c) 
than they do when bacteriocin release only occurs upon natural deaths (a, z= 0) during within-
patch competition. Inducible deaths promote the invasion of bacteriocin producers (e, f) relative 
to the lack of plasticity (d). At sufficiently high values of z, producers can invade even if 











Figure 4: Model results showing how frequency-dependent dispersal and density-dependent 
dispersal may affect the invasion of producers through the metapopulation. If dispersal or 
transmission is limited by the number of vectors, as in the case of the entomopathogenic 
nematode Xenorhabdus spp, the invasion success of the producer depends on its relative 
frequency within the host instead of total density. As shown in the figure, under frequency-
dependent selection, the consequences of scale of competition are lost. The figure shown here 
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Abstract   
 
Disease virulence may be strongly influenced by social interactions among pathogens, both 
during the time course of an infection and evolutionarily. Here we examine how spiteful 
bacteriocin production in the insect-pathogenic bacterium Xenorhabdus nematophila is 
evolutionarily linked to its virulence. Theory predicts a negative correlation between virulence 
and spite due to their inverse correlations with pathogen growth. We examined bacteriocin 
production and growth across 14 experimentally evolved lineages that show faster host-killing 
relative to their ancestral population. Consistent with theory, these evolved, more virulent 
lineages showed reduced bacteriocin production and faster growth relative to the ancestor. 
Further, bacteriocin production was negatively correlated with growth across the examined 
lineages. These results strongly support an evolutionary trade-off between virulence and spiteful 
bacteriocin production and lend credence to the view that disease management can be improved 










The degree of damage caused by a pathogen to its host, i.e. the pathogen’s virulence, is a 
complex trait determined by various factors. Key among these are the social interactions between 
the pathogens co-inhabiting a host (Frank, 1996; Leggett et al., 2014). Pathogens exhibit myriad 
forms of social behaviors, such as cooperation and cheating (Foster, 2005; Köhler et al., 2009). 
The direction of the effect of a given social behavior on virulence depends on how a behavior 
influences pathogen growth within the host (Gardner et al., 2004; Buckling & Brockhurst, 2008). 
Faster growing pathogens are often assumed to be more virulent. Therefore, social traits that 
promote faster pathogen growth, such as the production of cooperative public goods may be 
positively correlated with disease virulence (Griffin et al., 2004; Harrison et al., 2006). On the 
other hand, social behaviors such as spite that can decrease the growth of pathogen populations 
are expected to be negatively correlated with virulence (Gardner et al., 2004). Importantly, if 
these relationships have an underlying genetic basis, then the evolution of virulence may affect 
the evolution of social traits as well.  
 
Almost all known lineages of bacteria exhibit the spiteful trait, bacteriocin production 
(Klaenhammer, 1988; Riley & Chavan, 2006). Bacteriocins are anticompetitor toxins that can 
kill closely related strains without killing clone-mates of the producer cells (Reeves, 1965). 
Bacteriocin production can reduce the growth of producing populations as bacteriocins are 
metabolically costly to produce and they are often released by cell lysis (Riley & Wertz, 2002; 
Riley & Chavan, 2006; Wloch-Salamon et al., 2008). These negative effects on both the fitness 
of the producers and their sensitive competitors classifies bacteriocin production as a spiteful 






production and virulence as both the killing effect of bacteriocins and the growth costs of 
production can result in reduced pathogen densities, and thus, reduced virulence (Gardner et al., 
2004). 
 
Empirical studies have shown that bacteriocin-mediated competitive interactions can 
reduce virulence during mixed infections. For instance, during co-infections with a sensitive 
competitor strain, the addition of bacteriocin-producing Pseudomonas aeruginosa lineages 
results in lower pathogen densities and thus, reduced virulence relative to bacteriocin non-
producing mutants (Inglis et al., 2009). Similarly, bacteriocin-meditated interactions among 
insect-pathogenic Xenorhabdus spp. within a host lead to reduced virulence (Massey et al., 2004; 
Vigneux et al., 2008; Bashey et al., 2012). However, evolutionary trade-offs between virulence 
and spite remain less well understood. Very few studies have examined the relationship between 
the evolution of spiteful traits and virulence evolution. However, Garbutt et al. (2011) found that 
evolution in mixed infections can result in reduced virulence and increased competitive 
antagonism relative to evolution in single infections in the insect-pathogen Bacillus thuringiensis 
(Garbutt et al., 2011). Specifically, the increased antagonism occurred without a significant 
increase in absolute growth rates, suggesting that the observed antagonism was likely 
bacteriocin-mediated. Nonetheless, it is currently unclear if levels of bacteriocin production can 
be directly affected by selection on virulence.    
 
Here, we examine the evolutionary interplay between virulence, spite and growth in the 
insect-pathogenic bacterium, Xenorhabdus nematophila. Using an experimental evolution 






spiteful bacteriocin production. We also examine the growth of the evolved and ancestral 
lineages to investigate the underlying correlation between growth and bacteriocin production.  
 
 
Materials and Methods 
 
Study System: Xenorhabdus nematophila is a species of insect-pathogenic bacteria that forms a 
mutualistic symbiosis with the nematode Steinernema carpocapsae (Martens et al., 2003; 
Herbert & Goodrich-Blair, 2007; Stock & Blair, 2008). Free-living juvenile nematodes carry the 
bacteria in a specialized receptacle of the intestine, existing in a non-feeding state until they 
locate an insect host (Martens et al., 2003). Within the insect, the nematode and bacteria 
separate, replicate, and quickly kill the insect host (Burman, 1982; Dunphy & Webster, 1988). 
Bacteriocin-mediated interactions between co-infecting Xenorhabdus strains are known to occur 
within the insect host (Morales-Soto & Forst, 2011).When host resources are depleted, the 
bacteria and nematodes re-associate to emerge and find a new insect-host (Martens et al., 2003).  
 
Bacterial Strains: Experimental evolution was conducted in a previous study (Morran et al., 
2016), where 16 independent lineages of X. nematophila derived from a single ancestral colony 
were passaged through Galleria mellonella caterpillar-hosts. In the next paragraph, we briefly 
describe the experimental evolution protocol used to generate these lineages. After 20 host 
passages, each bacterial lineage was injected into insect hosts and the mean time to host death 
was used as a measure of virulence (as shown in Figure 2a of (Morran et al., 2016)). Pairwise 
comparisons between each evolved lineage and the ancestor revealed that 14 of the 16 lineages 
showed significantly faster host-killing than the ancestor (Figure 1a). These 14 evolved lineages 






During every round of selection, each bacterial lineage was passaged by infecting 15 
larval G. melonella caterpillars each with approximately 4000 CFUs. Depending on the 
treatment, the caterpillars were either infected with nematodes that carried the bacteria (M+), or 
directly injected with the appropriate bacterial dose by the experimenters (M-). Selection for 
faster host-killing (S+) was imposed by choosing only the first dead insect host for subsequent 
passaging. In contrast, in the ‘S–’ treatment, a dead host was chosen at random. Emerging 
juvenile nematodes were used for subsequent passaging in the ‘M+’ treatments. For ‘M-’ 
treatments, bacteria were extracted from the dead caterpillar hosts, serially diluted, and plated on 
selective NBTA agar plates with 50 g/ml ampicillin (nutrient agar supplemented with 0.0025% 
(w⁄ v) bromothymol blue and 0.004% (w⁄v) triphenyltetrazolium chloride, pH = 8). After 36 
hours of growth, 20 colonies were picked and suspended in 1 ml phosphate buffered saline to 
repeat the infection process. A 20-colony slurry of the ancestral population was cryopreserved 
prior to experimental evolution, and similar 20-colony slurries of every experimental lineage 
were cryopreserved at the end of 20 host passages. Slurries were grown overnight in Luria-
Bertani Broth (LB) at 28 º C, and preserved as 20% glycerol solutions at -80 º C. Additional 
details are available in the original paper (Morran et al., 2016). 
 
Bacteriocin extraction: Pure cultures of the ancestral and evolved lineages were grown in 5ml 
LB until OD600 = 0.5 at which point 0.5g/ml Mitomycin C was added to chemically induce 
bacteriocins. After overnight incubation at 28º C, bacteriocin extracts were collected by 
centrifuging cultures at 1620 G for 5 minutes and filtering the supernatant through 0.45m 
filters. This procedure allows the bacteriocin to pass through while eliminating any cells in the 






colonies of the ancestral population. These extractions, as well as the growth measurements and 
bioassays described below, were conducted in 4 experimental blocks, such that 4 evolved 
colonies and 1 ancestral colony were processed simultaneously.  
 
Growth measurements: The pure cultures used to extract bacteriocins were monitored for 
growth via periodic OD600  measurements on a spectrophotometer. OD600 values for all cultures 
after 4.5 hours of growth were used to compare growth rates. This time point was chosen as it 
was after all cultures reached exponential phase (OD600 > 0.2) and before Mitomycin C was 
added to the fastest growing culture. 
 
Bacteriocin bioassay: The inhibitory activity of the bacteriocin extracts derived from the 
evolved and ancestral lineages were compared using a growth inhibition bioassay (Bhattacharya 
et al., 2018). Briefly, a bacteriocin extract (or culture media in the ‘no bacteriocin’ controls) and 
a starting culture of sensitive cells (~106 CFU/ml) were mixed in 1:5 ratio by volume. Each 
mixture was pipetted into 4 replicate wells on a 100-well plate and incubated in a Bioscreen 
optical plate reader at 28 º C  with shaking at medium amplitude for 24 hours (GrowthCurves 
USA). Control wells with un-inoculated media were included to rule out contamination across 
the plate. OD600 measurements were taken every 30 minutes. These readings were used to 
calculate the lagtimes of the cultures growing in each well with the software GrowthRates 3.0 
(Hall et al., 2013).  
 The lagtime values of the cultures growing in the presence and absence of bacteriocin 
extracts were used to derive a metric of bacteriocin activity we call ‘relative lag time’. The 






bacteriocin extracts and the lagtime of the respective ‘no bacteriocin’ control. Since the metric is 
a ratio, a value of 1 indicates no bacteriocin activity was detected. For every bacteriocin sample, 
the growth inhibition bioassay was conducted across two distinct strains, Photorhabdus 
luminescens TT01 and X. bovienii MC19, which are both sensitive to X. nematophila bacteriocin.  
 
Statistical Analyses: All statistical analyses were performed using SAS 9.4. An analysis of 
variance was performed to conduct pairwise comparisons of ‘mean time to host death’ between 
the ancestor and the evolved lineages using Proc Mixed with ‘Lineage’ as a fixed effect. 
Bacteriocin activity (relative lag time) was compared using mixed-model analyses of variance 
with ‘treatment’ (Ancestral or Evolved), ‘sensitive strain’ (P. luminescens or X. bovienii), and 
their interaction as fixed effects; ‘lineage’ and ‘experimental block’ were included as random 
effects. Growth (OD600 at 4.5 hours) was analyzed similarly, with treatment and experimental 
block as factors. Pearson’s correlation coefficient between bacteriocin production and growth 
was determined using Proc Corr. To evaluate the significance of this correlation, while 
accounting for the repeated bacteriocin measures (i.e. tested against two sensitive strains), Proc 
Mixed was used with ‘relative lag time’ as the dependent variable and ‘OD’ as a fixed effect; 
‘Experimental block’ and ‘Lineage’ were included as random effects. 
 
Results 
The evolved lineages used here exhibited significantly faster host-killing, and thus, greater 
virulence relative to their ancestor (Figure 1a). Bacteriocin production in the evolved and 
ancestral lineages was tested against two sensitive strains using a growth inhibition bioassay. The 






15.30, p <0.001) compared to the ancestral population (Figure 1b), indicating reduced 
bacteriocin production evolved over time. There was no significant effect of sensitive strain (F1, 
15 = 0.03, p = 0.864) or interaction between treatment and sensitive strain (F1, 15 = 0.04, p = 
0.839). Additionally, the evolved, more virulent lineages also show significantly higher OD600 
values after 4.5 hours of growth (F1, 13 = 4.73, p = 0.049) relative to the ancestral strain (Figure 
2a). Relative lag time and growth were negatively correlated across strains (Figure 2b), with 
greater growth coming at the expense of lower bacteriocin activity (F1, 17 = 9.21, p = 0.008). 




Increasing evidence suggests that the virulence of pathogenic microbes may be affected by their 
social traits. Theory predicts a negative correlation between virulence and spite because 
virulence is often dependent on pathogen growth, and spite can result in lower growth of 
pathogenic populations (Gardner et al., 2004). A premier example of spiteful behaviors in 
bacteria is the production of bacteriocins (Riley & Chavan, 2006). Here, we examined how the 
evolution of virulence affects growth and bacteriocin production using experimentally evolved 
lineages (Morran et al., 2016) of the insect-pathogenic bacterium, Xenorhabdus nematophila. 
We found that the evolved, more virulent lineages (Figure 1a) exhibited reduced bacteriocin 
production and faster growth in vitro relative to their ancestor (Figure 1b, 2a). Further, 








Within-host competition among co-infecting pathogens can influence disease virulence in 
diverse ways. Increased competition for resources may select for faster pathogen growth and 
thus, increased virulence during mixed infections relative to single infections (de Roode et al., 
2005). But spiteful competitive interactions during mixed infections can reduce pathogen 
densities and select for reduced virulence (Massey et al., 2004; Vigneux et al., 2008; Inglis et al., 
2009). Relatively little is known about how virulence and spiteful competition are evolutionary 
linked. Here we show that the evolution of increased virulence is associated with reduced 
bacteriocin production and faster growth in X. nematophila. It is important to note that during the 
course of experimental evolution these lineages did not encounter any bacteriocin-sensitive 
competitors. In the absence of competitors, selection for the maintenance of bacteriocin 
production should be weak, which can thereby facilitate the evolution of faster growth via 
reduced investment in bacteriocin production. Consistent with this idea, it has been shown that 
evolution during mixed-infections can select for increased antagonism and reduced virulence 
relative to single infections (Garbutt et al., 2011). Taken together, these studies highlight the 
importance of competitive interactions in determining the evolutionary trajectory of pathogens 
(Bashey, 2015). 
 
There has been considerable interest in exploring the relationship between virulence and 
social behaviors in pathogens for the possibility of exploiting it for therapeutic application 
(Foster, 2005; Brown et al., 2009; Allen et al., 2014). Cooperative bacterial traits such as public 
goods production and quorum sensing (Griffin et al., 2004; Rumbaugh et al., 2009) have 
received particular attention in this regard, as exploiting the ability of ‘social cheats’ to invade 






al., 2006; Sandoz et al., 2007). The tradeoffs between virulence and spite reported here, and as 
seen in reports of mixed infections (Massey et al., 2004; Vigneux et al., 2008; Garbutt et al., 
2011) suggest that maintaining selection for spite may help constrain the evolution of virulence. 
Akin to using ‘social cheats’ as therapeutic agents, perhaps the use of live competitors to 
maintain selection for bacteriocin production could help constrain pathogen growth and thus, 
reduce virulence. Genetically engineered probiotics that are being developed for therapeutic use 
(Sola-Oladokun et al., 2017) may serve as potential candidates for such treatment strategies.  
 
To conclude, we investigated how the evolution of increased virulence is associated with 
spiteful bacteriocin production and growth in insect pathogenic X. nematophila. Consistent with 
predictions, we found that the evolution of increased virulence is associated with reduced 
bacteriocin production and faster growth in vitro. Such trade-offs between virulence and spite 
may offer novel opportunities to exploit social traits in pathogenic populations for disease 
management. These results provide some of the earliest direct insights into how the evolution of 
virulence and bacteriocin production are correlated and demonstrate how the social lives of 
pathogenic bacteria may be intricately linked with disease.  
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Figure 1: Increased virulence (a) of the14 evolved lineages (grey bars) relative to the ancestor 
(black bar) is shown as a lower mean (+/- s. e.) time to host death. Reduced bacteriocin 
production (b) is shown as a lower mean (+/- s. e.) relative lag time, indicating that the 
bacteriocin extracted from the evolved lineages was less inhibitory than the bacteriocin extracted 










Figure 2: Evolved, more virulent lineages grow faster than the ancestor (a) and show a 
significant negative correlation with bacteriocin production (b). Growth is shown as mean (+/- s. 
e.) OD600 after 4.5 hours culturing in vitro. Bacteriocin production is shown as the relative lag 
time value exhibited by all evolved and ancestral lineages against both sensitive strains. 











Suppression of bacteriocin resistance using live, heterospecific competitors 
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Rapidly spreading antibiotic resistance has led to the need for novel alternatives and sustainable 
strategies for antimicrobial use. Bacteriocins are a class of proteinaceous anticompetitor toxins 
under consideration as novel therapeutic agents. However, bacteriocins, like other antimicrobial 
agents, are susceptible to resistance evolution, and will require the development of sustainable 
strategies to prevent or decelerate the evolution of resistance. Here we conduct proof-of-concept 
experiments to test whether introducing a live, heterospecific competitor along with a bacteriocin 
dose can effectively suppress the emergence of bacteriocin resistance in vitro. Previous work 
with conventional chemotherapeutic agents suggests that competition between conspecific 
sensitive and resistant pathogenic cells can effectively suppress the emergence of resistance in 
pathogenic populations. However, the threshold of sensitive cells required for such competitive 
suppression of resistance may often be too high to maintain host health. Therefore, here we aim 
to ask whether the principle of competitive suppression can be effective if a heterospecific 
competitor is used. Our results show that a live competitor introduced in conjunction with low 
bacteriocin dose can effectively control resistance and suppress sensitive cells. Further, this 






bacteriocin. These results provide strong proof-of-concept for the effectiveness of competitive 
suppression using live, heterospecific competitors. Currently in-use probiotic strains or 





Rapidly spreading antibiotic resistance has created an urgent need to find novel antimicrobials 
(Projan & Shlaes, 2004; Allen et al., 2014) and usage strategies that can constrain the emergence 
of resistance (Olofsson & Cars, 2007; Read et al., 2011). One potential source of alternative 
antimicrobials is bacteriocins, which are proteinaceous toxins produced by bacteria, noted for 
their ability to kill closely related strains (Cotter et al., 2013). Bacteriocins are ubiquitously 
produced by almost all known lineages of bacteria, (Klaenhammer, 1988; Riley & Chavan, 2006) 
increasing their appeal as potential alternatives to replace antibiotics. However, resistance 
against bacteriocins has been frequently reported in natural as well as clinical isolates (Gordon et 
al., 1998; Hawlena et al., 2010b; Koch et al., 2014), and relative to conventional antibiotics, 
little is known about the evolution of resistance against bacteriocins (Inglis et al., 2016). Here we 
examine the evolution of resistance against bacteriocins in the insect-pathogenic bacteria 
Xenorhabdus bovienii and conduct in-vitro experiments to investigate a novel strategy for 
preventing the emergence of resistance. 
 
The traditional approach of aggressive chemotherapy used with conventional 
antimicrobials employs high doses with the goal of eliminating all pathogen cells including 






approach imposes strong selection favoring resistant mutants that may be present at the onset of 
infection or be acquired over the course of infection (Read et al., 2011; Day & Read, 2016). 
Recent studies have proposed a ‘moderate chemotherapy’ or ‘containment’ approach that is more 
effective at suppressing resistant mutants from spreading. Moderate chemotherapy employs 
lower antimicrobial doses than aggressive approaches and does not eliminate all sensitive 
pathogenic cells. Competition between the untreated sensitive cells and resistant mutants results 
in competitive suppression of resistance and thereby prevents the spread of resistant mutants (de 
Roode et al., 2004; Kouyos et al., 2014; Hansen et al., 2017; Wale et al., 2017). However, the 
success of this approach depends critically on maintaining a threshold density of sensitive cells 
for competitive suppression of resistance to occur. If this threshold is too high for a host to 
tolerate without succumbing to the infection, moderate chemotherapy will be ineffective. Under 
such circumstances, aggressive approaches are recommended (Hansen et al., 2017), which can 
be problematic as they impose strong selection for resistance. Thus, for sustainable use of 
antimicrobials, it is necessary to find strategies that can simultaneously achieve two major goals: 
(a) effective suppression of pathogen cell densities, and (b) prevention of resistance evolution. 
 
Over the course of debates on the relative efficacy of aggressive versus moderate 
treatment strategies, competition between drug-sensitive and drug-resistant pathogenic cells has 
repeatedly surfaced as a key determinant of the emergence and spread of resistance (de Roode et 
al., 2004; Huijben et al., 2010; Colijn & Cohen, 2015; Day et al., 2015). Although models 
specifically emphasize competition between conspecific drug-sensitive and drug-resistant cells, 
the conceptual framework that underpins the role of competition in constraining resistance 






whether it is a conspecific sensitive strain or heterospecific neighbor, may impose similar 
constraints on the spread of resistant mutants of the target strain if the competitor itself is 
unaffected by the antimicrobial used.  
 
Here, we examine whether the conceptual basis of competitive suppression of resistance 
can be extended to include heterospecific competitors. We examine the evolution of resistance 
against bacteriocins and conduct in-vitro, proof-of-concept experiments to determine whether 
using a heterospecific competitor strain in conjunction with bacteriocin dose, can constrain the 
spread of resistant mutants in the population while also driving down densities of bacteriocin-
susceptible pathogenic cells. We expect high bacteriocin doses to impose selection favoring 
resistant mutants. In contrast, we predict that incorporating a heterospecific competitor with the 
high bacteriocin dose will reduce the emergence of resistance as the additional competitive 
challenge will impede the spread of resistant mutants. We further predict that low bacteriocin 
doses will result in lower selection for resistance than high doses; however, low doses may not 
effectively suppress total cell densities. We predict that using a competitor with low bacteriocin 
doses will not only slow the evolution of resistance but will also suppress untreated sensitive 
cells resulting in a better overall outcome relative to using the low dose without a competitor. 
Additionally, we predict that using only a competitor that itself produces a low dose of the 
bacteriocin should be effective at reducing total and resistant cell densities of the focal, target 
strain. Finally, these predictions rely on the assumption that resistance imposes a cost that makes 
resistant mutants inferior competitors to their sensitive counterparts. Thus, to determine whether 
resistance is indeed costly in our experiments, we also compare the growth of resistant mutants 






Materials and Methods 
Experimental Design: To examine the effect of dose on the growth of sensitive cells and 
evolution of bacteriocin resistance, cultures of a bacteriocin-sensitive strain, Xenorhabdus 
bovienii, were exposed to two different doses of bacteriocin (high and low) and a ‘no 
bacteriocin’ control. The effect of competitive suppression was examined by either introducing a 
live competitor strain in conjunction with the bacteriocin dose (‘high dose + competition’ and 
‘low dose + competition’) or exposing cells to bacteriocin alone. Finally, the effect of a 
bacteriocin-producing competitor alone was examined by introducing a competitor that produces 
a low dose of the bacteriocin to the cultures of the sensitive strain (bacteriocin-producing 
competitor). In all treatments, we determined both total and resistant cell densities of the focal, 
target strain Xenorhabdus bovienii. 
 
Bacterial Strains: A natural isolate of the bacteriocin-sensitive strain Xenorhabdus bovienii, 
Bov59 (isolated as described in Hawlena et al., 2010b), was used as the focal, target strain. Both 
high and low doses of bacteriocin were derived from a natural isolate of X. koppenhoefferi, 
Kop46 (isolated as described in (Hawlena et al., 2010a)), which is also a sympatric competitor of 
the bacteriocin-sensitive strain (Hawlena et al., 2012). The competitor used in the ‘high dose + 
competitor’ and ‘low dose + competitor’ treatment was a mutant X. koppenhoefferi strain (Kop46 
mut) that does not release functional bacteriocin (construction as described in Morales-Soto & 
Forst, 2011). For the ‘bacteriocin-producing competitor’ treatment, the wild type Kop46 strain 
was used. These strains of X. koppenhoeferi and X. bovienii are morphologically distinct 
whereby Kop46 colonies appear maroon and Bov59 colonies appear blue on NBTA plates 






0.004% (w⁄ v), 5 triphenyltetrazolium chloride (Sigma Aldrich), pH = 8). In addition, Bov59 has 
a higher natural resistance to ampicillin than Kop46, thereby enabling further distinction on 
NBTA plates with 75μg/ml ampicillin. All cultures used in the experiment were derived from 
freezer stocks maintained at -80ºC and streaked onto NBTA plates prior to each replicate. 
 
Bacteriocins: Bacteria in the genus Xenorhabdus produce a phage tail-like bacteriocin, 
xenorhabdicin (Boemare et al., 1992; Thaler et al., 1995). Like most bacteriocins, xenorhabdicin 
has a narrow killing range, affecting other Xenorhabdus strains and strains in the closely related 
genera Photorhabdus and Proteus. Xenorhabdicin is similar in structure to R-type pyocins, 
where killing requires attachment of tail fibers to the target cell and results from a puncture and 
subsequent depolarization of the cell membrane (Williams et al., 2008). Xenorhabdicin is 
encoded by a remnant P2 phage cluster, approximately 30 kb in length (Morales-Soto & Forst, 
2011; Morales-Soto et al., 2012; Ciezki et al., 2017). Growth inhibition of the target strain 
Bov59 by the xenorhabdicin produced by Kop46 was determined by insertional inactivation of 
the sheath gene and subsequent lack of inhibitory phenotype observed in the mutant phenotype 
(Bashey, Forst, and Palmer, unpublished data).  
 
Bacteriocin Doses: Both high and low doses of the bacteriocins used were procured from wild 
type Kop46 cultures. High dose bacteriocin extracts were collected from Kop46 cultures that 
were chemically induced with Mitomycin C (Sigma Aldrich). Briefly, pure cultures of Kop46 
cultures in exponential phase were incubated with 0.5g/ml Mitomycin C. After overnight 
incubation at 28º C, bacteriocin extracts were collected by centrifuging cultures at 1620 G for 5 






the bacteriocin to pass through while eliminating any cells in the extract. Previous work with this 
isolate has shown that PEG precipitations of filtered supernatants (to further isolate the phage 
tail-like bacteriocins) show identical patterns of inhibitory activity as the un-precipitated doses 
used here, when tested against over 10 different target genotypes. Further, no active phage has 
been found in the strains used in this study (Hawlena et al., 2010a). 
 
The low dose was obtained from stationary phase cultures of Kop46 without chemical 
induction. This choice of the low dose of bacteriocin was deliberate to ensure that the amount of 
bacteriocin produced by the competitor in the ‘bacteriocin-producing competitor only’ treatment 
matched the low dose used in the ‘low dose + competition’ treatment. This is further confirmed 
by earlier work showing that the concentration of bacteriocin produced by Kop46 is not affected 
by co-culturing with Bov59 (Bhattacharya et al., 2018). Finally, the inhibitory profile of Kop46 
bacteriocin with and without chemical induction was identical in 9 tested strains, indicating that 
the same antimicrobial is released at both doses used in the experiment. All bacteriocin extracts 
were stored at 4º C until used. 
 
Bioassay to quantify high and low bacteriocin doses: A growth inhibition bioassay 
(previously described in Bhattacharya et al., 2018) was used to quantify and compare the high 
and low doses of bacteriocin used in the experiments. This bioassay compares the inhibitory 
effect of different bacteriocin doses by comparing the duration of lag imposed on the growth of a 
sensitive strain by fixed amounts of the bacteriocins. To do this, we mixed a bacteriocin dose (or 
culture media in the ‘no bacteriocin’ control) and a starting culture of sensitive cells in 1:5 ratio 






was measured on a Bioscreen optical plate reader (GrowthCurves USA). The doses examined in 
this experiment included the chemically induced ‘high dose’, three 10-fold serial dilutions of the 
high dose, and the ‘low dose’ derived from chemically uninduced Kop46 cultures. Four replicate 
wells of each bacteriocin dose were examined in a 100-well plate reader (Honeycomb plate, 
Growth Curves USA). Each well contained 200l of the respective bacteriocin + culture mixture 
at an initial density of 106 CFU/ml. Control wells with un-inoculated media were included to rule 
out contamination. The plates were incubated in the optical plate reader at 28º C with continuous 
shaking at medium amplitude, and OD600 was recorded every 30 min for 24 hours.  
 
The OD600 data was used to generate growth curves, and the lag time of the cultures 
growing in each well was calculated using the software GrowthRates 3.0 (Hall et al., 2013). Lag 
time represents the time taken by a starting culture to reach exponential growth phase. The 
inhibitory activity of bacteriocins results in increased lag times of cultures that are exposed to 
bacteriocins relative to negative control cultures that are not exposed to bacteriocins (Figure 1). 
This increase in lag time provides a metric of bacteriocin inhibitory activity and thus dose. A 
growth inhibition bioassay revealed that the lag times of Bov59 cultures exposed to the ‘high 
dose’ bacteriocin were significantly longer than the lag times of cultures exposed to ‘low dose’ 
bacteriocin (F1,18 = 62.41, p <0.0001, Figure 1).The ‘low dose’ bacteriocin imposed significantly 
greater growth inhibition than the ‘no bacteriocin’ control (F1,18 = 130.64, p <0.0001), 1:1000 
dilution (F1,18 = 132.25, p <0.0001), 1:100 dilution (F1,18 = 94.09, p <0.0001)  and significantly 







Experimental protocol to determine the effects of dose and competition: Starting cultures 
(~106 CFU/ml) of bacteriocin-sensitive Bov59 were established by inoculating 5ml LB media 
(Difco) with 100l of an overnight culture in 20ml culture tubes. To examine the effect of dose 
on the evolution of bacteriocin resistance, cultures were either exposed to 1ml of bacteriocin 
dose (high or low), or 1ml additional LB (‘no bacteriocin’ control). The effect of competitive 
suppression was examined by either introducing a live competitor strain (Kop46 mut) in 
conjunction with the bacteriocin dose or exposing cells to bacteriocin alone. The mutant Kop46 
strain was co-inoculated in the competition treatment tubes (50l of an overnight culture), in 
addition to the respective bacteriocin dose. Finally, the effect of a bacteriocin-producing 
competitor alone was examined by directly co-inoculating 50ul of overnight cultures of a 
bacteriocin-producing competitor (Kop46) without any additional bacteriocin dosage. All 
cultures were incubated for 24 hours at 28º C with shaking at 120 rpm (New Brunswick C2 
platform shaker, Easton NJ). Nine independent experimental replicates of all the treatments were 
performed. 
 
After 24 hours, serial dilutions were plated to estimate total and resistant cell densities of 
the focal, target strain Bov59, as well as, densities of the heterospecific competitors. Total 
density of the Bov59 cells was estimated by plating 100ul of the culture dilutions on NBTA agar 
plates with 75μg/ml ampicillin (NBTA+Amp75). Both bacteriocin-sensitive and bacteriocin-
resistant Bov59 cells can grow on these plates but the heterospecific competitor used in the 
experiment does not grow on these plates. Moreover, the Kop46/Kop46 mutant colonies are 







To determine resistance, 100ul aliquots of the dilutions were mixed with equal volumes 
of chemically induced bacteriocin before plating (as in Bashey, Young, Hawlena, & Lively, 
2012) allowing only resistant colonies to grow. This method of measuring resistance evolution 
was independently validated as is described in following section. Colony counts for total Bov59 
and bacteriocin-resistant Bov59 determined from these plates were used to calculate the 
proportion of resistant mutants in each treatment. Additionally, one dilution was plated on 
NBTA agar plates without ampicillin which is a non-selective media plate and thus confirmed 
the absence of contamination in cultures. In all cases where no colonies were detected on a plate, 
the detection limit of cell density for that plate was used instead of zero, to be as conservative 
with estimates as possible. 
 
Growth inhibition bioassay to validate resistance evolution: To validate the method used for 
detecting resistance evolution, 10 colonies from one replicate of the ‘high dose’ treatment were 
chosen at random. These 10 test colonies were derived from a NBTA+Amp75 plate used to 
calculate total Bov59 density. The colonies were picked, inoculated in 5ml LB media overnight 
and then used to conduct a growth-inhibition bioassay as described above in the Bioassay 
section. All 10 test colonies, and a bacteriocin-sensitive, wild type Bov59 culture were grown in 
the presence and absence of chemically induced bacteriocin. Starting cultures were mixed with 
bacteriocin or additional growth media in a 5:1 ratio, and growth of the cultures was measured in 
an optical plate reader. OD600 readings were taken every 30 minutes for 24 hours. The resulting 
growth curves were examined to look for bacteriocin-mediated inhibition. Typically, sensitive 
cultures show strong bacteriocin-mediated inhibition of growth depicted by increased lag times 






Resistance was determined as the lack of strong inhibition in the presence of bacteriocin. Among 
the examined colonies, 9 out of 10 showed resistance. The resistant colonies showed a 
significantly shorter lag time when exposed to bacteriocin (mean +/- S.E.M = 42.62 +/- 7.9 
minutes) relative to the sensitive cultures (mean +/- S.E.M = 1263.71 +/- 46.68 minutes, t= 
25.79, df = 1, p = 0.02) The proportion of resistant colonies (9 out of 10, i.e. 90%) was consistent 
with the proportion calculated for that replicate (89.13%) by comparing Bov59 CFUs from 
plating with and without bacteriocin, thereby validating the experimental methods used to 
measure resistance evolution. 
 
Cost of resistance: To determine whether the evolution of resistance against bacteriocins is 
associated with growth costs, growth parameters while growing in the absence of bacteriocin 
were compared for sensitive and resistant colonies isolated from two independent experiments. 
First, we examined the 10 test colonies derived from the current experiment described in the 
previous paragraph. Growth parameters in the absence of bacteriocin for the 9 resistant colonies 
were compared to growth parameters of the sensitive colony and a wild type Bov59 colony. 
OD600 values for four replicate wells for each colony were measured by the Bioscreen optical 
plate reader and were used to estimate colony average growth rate and maximum OD values by 
the software GrowthRates 3.0 (Hall et al., 2013). These colony averages were used to compare 
growth between resistant and sensitive colonies. 
 
Resistant colonies were also isolated from an independent experiment. In this second 
experiment, initial cultures of wild-type Bov59 were grown in the presence (Exposed) and 






plate, Growth Curves USA). Four independent replicates from each condition were pooled and 
serial dilutions were plated on NBTA agar plates. Five separate colonies from each treatment 
(Exposed and Negative) were preserved by growing overnight in LB and making freezer  
stocks in glycerol, which were stored at -80ºC. The freezer stocks were used to conduct growth 
inhibition bioassay as described above. All five ‘Exposed’ stocks showed resistance to 
bacteriocins, while all five ‘Negative’ treatment stocks showed bacteriocin sensitivity. Growth 
parameters of these colonies in the absence of bacteriocin were determined as described in the 
previous paragraph.  
 
Statistical analysis: The effect of different bacteriocin doses on the lagtimes of a sensitive 
Bov59 cultures were compared by performing a one-way analysis of variance using ‘bacteriocin 
dose’ as a fixed effect in Proc Mixed. To compare the effect of bacteriocin dose and the presence 
of a competitor on log10-transformed cell densities and proportion resistance values, mixed 
model analyses of variance with ‘bacteriocin dose’ and ‘competition’ as fixed effects and 
‘experimental block’ as random effect were used in Proc Mixed. Bacteriocin-induced delay in 
lagtime, growth rates, and maximum OD values of sensitive and resistance cultures were 
compared using Proc Ttest with the Satterthwaite approximation to account for unequal variance 
and sample sizes. To visualize growth of resistant and sensitive colonies, a LOESS regression on 
the colony average OD was used to estimate the mean OD per time for each type of colony 












Exposure to high bacteriocin dose reduces total Bov59 densities but imposes strong 
selection for resistance: Exposure to a high dose of bacteriocin resulted in significantly lower 
total Bov59 cell densities (Figure 2A) than the ‘no bacteriocin’ (F1,16 = 87.23, p < 0.0001) and 
‘low-dose bacteriocin’ treatments (F1,16 = 83.53, p < 0.0001). Specifically, the high dose 
treatment had over an order of magnitude reduction in total Bov59 densities (high dose CFU/ml 
= 6.6 x 10
6
 vs 7.8 x 10
7
and 7.1 x 10
7
 CFU/ml in the ‘no bacteriocin’, ‘low dose’ treatments, 
respectively). While this shows the effectiveness of the high dose in reducing total cell densities, 
exposure to the high dose of bacteriocin also imposed strong selection for bacteriocin resistance 
(Figure 2B). The resistant Bov59 density was 35- to 62-fold higher in the ‘high dose’ treatment 
(5.1 x 10
6 
CFU/ml) relative to the ‘no bacteriocin’ (mean CFU/ml = 2.1 x 10
5, F1,16 = 46.51, p = 
0.0001) and ‘low dose’ (mean CFU/ml = 5.1 x 10
5
, F1,16 = 15.52, p = 0.0012) treatments. 
Although the ‘low dose’ treatment had twice as many resistant cells as the ‘no bacteriocin’ 
treatment, this difference was not statistically significantly (F1,16 = 1.08, p = 0.31). Total Bov59 
densities measured in the low bacteriocin treatment were also not significantly different from the 
no bacteriocin treatment (F1,16 =0.05, p = 0.82). It was confirmed, however, that the low 
bacteriocin treatment showed inhibitory activity against the target strain, using a growth 
inhibition assay (Figure 1).  
 
Incorporating a live, heterospecific competitor with bacteriocin dose reduces total and 
resistant cell densities: To examine the effectiveness of competitive suppression, a live 






competitor significantly reduced the total (F1,24 = 45.2, p < 0.0001) and resistant Bov59 densities 
(F1,24 = 254.7, p < 0.0001) relative to the use of bacteriocins only at both doses (Figure 3). 
Further, adding the Kop46 mutant competitor reduced the percentage of resistant cells in the 
high-dose treatment from 83.6 % to 0.3 % (F1,24 = 128.14; p <0.0001), demonstrating that 
competition prevented resistant mutants from spreading in the population. For the low dose 
treatment percent resistance was 0.9% without the competitor. No resistant colony was detected 
in any of the nine replicates of the ‘low dose + competitor’ treatment, at a detection limit of 100 
CFU/ml; although, total Bov59 density was on the order of ~10
5
 CFU/ml for this treatment. 
Overall, the ‘low dose + competitor’ treatment yielded the lowest total and resistant cell densities 
in the target strain (Figure 3). 
 
Despite the overall reduction in total cell densities upon the addition of a live, 
heterospecific competitor, the ‘high dose + competitor’ treatment maintained a significantly 
higher density of Bov59 cells (mean CFU/ml = 1.8 x 10
6
) relative to the ‘low dose + competitor’ 
treatment (mean CFU/ml = 6.5 x 10
3
, F1,24 = 01.04; p <0.0042). Such high total densities of 
Bov59 in the ‘high dose + competition’ treatment may reflect the escape of resistant mutants, 
despite a strong reduction in percent resistance upon the addition of the Kop46 mutant 
competitor. The density of resistant cells in the ‘high dose + competitor’ treatment (mean 
CFU/ml = 1999.11) was significantly higher than the resistant cell density in the ‘low dose + 
competitor’ treatment (mean CFU/ml = 99 , F1,24 = 15.92; p =0.0005). For replicates where no 
resistant colonies were found, the resistant cell density calculations used the detection limit 






competition’ treatment resulting in mean CFU/ml = 99 which was the detection limit, resistance 
was detected in one replicate of the ‘high dose + competition’ treatment at a density of 10000 
CFU/ml suggesting that the likelihood of resistance escape was higher in the latter treatment. 
The mean density of the Kop46 mutant competitor itself was 0.9 x 10
6
 CFU/ml in the ‘high dose 
+ competitor’ treatment and 1.2 x 10
8
 CFU/ml in the ‘low dose + competitor’ treatment.  
 
Competition with bacteriocin-producing competitor alone effectively suppresses total and 
resistant Bov59 densities: We examined whether using a bacteriocin-producing strain, which 
releases bacteriocin matching the concentration of the low-dose treatment, could be just as 
effective as the ‘low dose + competitor’ treatment. Total and resistant cell densities of the target 
strain in this treatment (Figure 3) show that this approach is as successful as the low dose with 
competition treatment in suppressing target cells (F1,8 = 2.57, p = 0.15) and constraining 
resistance (F1,8 = 1.0, p = 0.35). No resistant colonies were detected in 8 out of the 9 replicates 
examined at a detection limit of 100 c.f.u/ml. The remaining replicate showed 0.5% resistance. 




Resistant mutants pay a growth cost relative to sensitive cells: To determine whether resistant 
mutants pay a cost of resistance, we compared the growth in the absence of bacteriocin of 
resistant and sensitive colonies derived from two independent experiments. Nine resistant 
colonies from one “high dose” replicate of the main experiment were compared to the growth of 
the single sensitive culture from that replicate and a wild type Bov59 culture. Cultures derived 






lower growth rates (t = 3.87, df = 9, p = 0.003) and reach lower maximum OD values (t  = 5.29, 
df = 9, p = 0.0004). Growth of 5 bacteriocin-resistant and 5 bacteriocin-sensitive cultures derived 
from a separate experiment also show distinct patterns in the absence of bacteriocin (Figure 4B). 
Again, consistent with a cost of resistance, bacteriocin-resistant lineages show significantly 
reduced growth rates (t = 3.05, df = 4, p = 0.037) and a statistical trend towards lower maximum 
OD values (t = 2.48, df = 4, p = 0.06) relative to the bacteriocin-sensitive lineages.  
 
Discussion 
Conventional chemotherapeutic methods involving the use of high antibiotic doses may be 
effective initially, but as they impose strong selection favoring resistant mutants they ultimately 
result in treatment failure. Using lower doses can enable competitive suppression of resistance, 
when the host can tolerate susceptible pathogen loads that are sufficient to outcompete resistant 
mutants. However, using lower doses may not be feasible when the host cannot tolerate 
sufficient susceptible pathogenic cells to compete with resistant mutants. Here, we conduct in 
vitro experiments to test whether the principle of competitive suppression can be employed by 
using a heterospecific competitor in conjunction with antimicrobial dose to suppress resistance 
evolution, and overall pathogen load. We test this concept using bacteriocins and natural isolates 
of bacteriocin-producing Xenorhabdus populations. Our results suggest that incorporating a live 
competitor strain in conjunction with bacteriocin can significantly reduce the density of resistant 
cells. We find that the combination of low dose bacteriocin and a heterospecific competitor is 
most effective at suppressing overall cell densities and the evolution of resistance against 
bacteriocins (Figure 3). We demonstrate that the same efficacy may be achieved by using a 






simultaneously competes with the susceptible population. Finally, we find that the evolution of 
resistance against bacteriocins in vitro is associated with significant growth costs detectable in 
the growth rates as well as yield in cultures of resistant lineages relative to sensitive lineages 
(Figure 4). These results provide strong proof-of-concept for the effectiveness of employing 
competitive suppression to control the spread of bacteriocin resistance while also lowering 
susceptible cell densities.  
 
This study examines the evolution of resistance against bacteriocins, which are 
anticompetitor toxins ubiquitously produced by bacteria. Bacteriocins have been proposed as 
alternatives to replace the fast-depleting pool of antibiotics. In addition to being noted for their 
efficacy against pathogenic strains both in vitro (Noll et al., 2011; Sandiford & Upton, 2012) and 
in vivo (Goldstein et al., 1998; Kruszewska et al., 2004; De Kwaadsteniet et al., 2009), 
bacteriocins demonstrate low cytotoxicity to host cells (Maher & McClean, 2006; Jasniewski et 
al., 2009), contributing to their suitability as therapeutics (reviewed in Cotter et al., 2013; Riley 
et al., 2012). Bacteriocins typically have narrow killing spectra; although, some broad-spectrum 
bacteriocins are known (McAuliffe et al., 1998; Riley & Chavan, 2006; Lim et al., 2016). In the 
search for commercially viable therapeutics, broad killing spectra may seem appealing due to the 
wide range of pathogens one agent can treat. However, the potential risk of disrupting 
commensal microbial community within the host, and the increased potential for the evolution of 
resistance against the agent, may be important reasons to make narrow spectrum bacteriocins the 
favorable choice for sustainable therapeutic application (Rea et al., 2011). Further, the narrow-
killing range of bacteriocins may make them more amenable to the reduction of resistance 






competitor strain is required. Although bacteriocins have been less well-exploited as 
therapeutics, bacteriocin-production is known to play a key role in the efficacy of probiotic 
supplements. Many probiotic bacteria confer health benefits via bacteriocin-mediated 
competition resulting in their establishment in the microbiome (as reviewed by (Gillor et al., 
2009; Dobson et al., 2012). Additionally, some studies have found strong evidence to suggest 
that bacteriocin-producing probiotic strains can effectively inhibit pathogenic strains including 
enterohaemorrhagic Escherichia coli and Listeria monocytogenes (Su et al., 2007b; a), further 
highlighting the potential for using bacteriocins as alternative therapeutics to replace antibiotics. 
 
  However, this potential may be squandered if bacteriocins are used in a conventional 
chemotherapeutic approach. Our results demonstrate that exposure to high doses of bacteriocin 
can lead to rapid evolution of resistance (Figure 2). In contrast, using a heterospecific competitor 
in conjunction with a high bacteriocin dose can suppress the spread of resistant mutants (Figure 
3). The percent of resistant cells in the target population when a heterospecific competitor is 
added drops to 0.3% as compared to 87.6% in the presence of high dose without a heterospecific 
competitor. This striking reduction in the proportion of resistant cells when a competitor is 
present suggests that the heterospecific competitor was disproportionately constraining the 
spread of resistant mutants relative to sensitive cells. This observation is consistent with the 
hypothesis that resistant mutants pay costs of resistance that make them inferior competitors to 
their sensitive counterparts. We examined whether resistant mutants derived from exposure to 
high bacteriocin doses show growth costs. Across two independent experiments, we find that 
resistant cultures show significantly lower growth rates than sensitive cultures and achieve 







  We find that a low bacteriocin dose did not impose strong selection for resistance, but 
was less effective at suppressing total densities of the target strain than the high dose (Figure 2). 
However, we find that incorporating a heterospecific competitor with low bacteriocin dose can 
allow the use of a competitor strain can allow low bacteriocin dosage to effectively reduce target 
cell density and significantly reduces the emergence of bacteriocin resistance. Further, a 
bacteriocin-producing competitor used alone can be just as effective. These results provide 
promising leads to suggest that using a biotherapeutic agent such as a live, heterospecific 
competitor may confer increased sustainability to the use of bacteriocins as alternative 
therapeutics. The choice of the live competitor will be the most important, and perhaps, also the 
most limiting factor in the application of this therapeutic approach, as the competitor cells are 
expected to increase in density. Currently in-use probiotic strains may be the most viable 
candidates, and could be further engineered to attack specific targets (reviewed in Sola-
Oladokun, Culligan, & Sleator, 2017; Williams, Gebhart, Martin, & Scholl, 2008). Additional 
candidates may be found by screening commensal bacterial strains for specific bacteriocin 
activity (Lakshminarayanan et al., 2013), as pathogenic strains often have non-pathogenic 
relatives. For example, the commensal E. coli G3/10 produces a bacteriocin that can inhibit 
enteropathogenic E. coli E2348/69 and has been effectively used in the treatment of irritable 
bowel syndrome (Zschüttig et al., 2012). 
 
In summary, we have examined whether the concept of competitive suppression of 
resistance can be harnessed by incorporating heterospecific competitors in antimicrobial 






significantly suppressed by either incorporating a live, non-bacteriocin-producing competitor 
strain along with low bacteriocin dose, or using a bacteriocin-producing agent alone. Both these 
treatments also successfully suppress the overall density of target cells regardless of resistance 
phenotype. Our experiment provides proof-of-concept for the use of biotherapeutic agents as a 
template for future investigations. Conceptually, this approach should be applicable across other 
antimicrobials as well, and may be highly effective for treating a range of infections such as 
epithelial infections, including burns and wounds of the skin and mouth, as well as, 
gastrointestinal and lung infections, which can be recalcitrant to current therapies in 
immunocompromised, elderly, and cystic fibrosis patients. Future work investigating the efficacy 
of competitive suppression in spatially structured environments and in vivo models will lead to a 
greater understanding of the applicability of competitive suppression in treatment. In conclusion, 
we have provided proof-of-concept for a novel approach to impede the emergence of 
antimicrobial resistance, and provide a template for future investigations to explore in relevant 
disease settings.  
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Figure 1: Bacteriocin doses measured by induced growth-inhibition of sensitive strains. (A) 
Growth curves of a bacteriocin-sensitive strain when exposed to different bacteriocin doses. 
Doses include the chemically induced ‘high dose’ used in this study, three consecutive 10-fold 
dilutions of the high dose, and the ‘low dose’ which was derived from chemically uninduced, 24-
hr cultures of the bacteriocin producing strain. Each marker point represents an average OD600 
value of four technical replicates. (B) Mean+/- S.E.M. lag times of the bacteriocin-sensitive 
cultures exposed to the different bacteriocin doses. Exposure to higher bacteriocin doses results 










Figure 2: Effectiveness of bacteriocin dose (A) and evolution of resistance (B) in response to 
exposure to no, low, or high doses of bacteriocin. Total cell densities of the target strain Bov59 
(A) are significantly lower in the high bacteriocin treatment as compared to low bacteriocin and 
negative control. However, the density of resistant Bov59 cells (B) of the target strain is 
significantly higher in the high bacteriocin treatment than other treatments. Data are shown as 
log10 (CFU/ml) after 24-hour exposure. Gray circles represent the mean of 9 experimental 
replicates with 95% confidence intervals. Detection limit for cell density counts was 10
5
 CFU/ml 
for the ‘low dose’ and ‘no bacteriocin’ treatments, and 10










Figure 3: Suppression of total Bov59 density (A) and evolution of resistance (B) in response to 
bacteriocin exposure and competitive suppression. Only high and low doses of bacteriocin were 
administered in the bacteriocin only groups, while a live competitor was introduced in addition 
to bacteriocin doses in the competitive suppression group. The addition of a competitor 
significantly reduced the total cell densities (A) as well as resistant cell densities (B) of the target 
strain Bov59 at both doses of bacteriocin (* p < 0.0001). The combination of low dose and 
competitor was particularly effective at suppressing total cell densities (Dose x Competitor 
interaction: F1,24 = 13.8, p = 0.001), most likely due to the low levels of evolved resistance. 
Exposure to a bacteriocin-producing competitor alone was as effective as the low dose with 
competition treatment (n.s., p > 0.05). Data are shown as log10 (CFU/ml) after 24-hour exposure. 
Each symbol represents the mean of 9 experimental replicates with 95% confidence intervals for 
the respective treatment. Detection limit was 10
3 CFU/ml for the ‘high dose + competitor’ 









Figure 4: Cost of bacteriocin resistance as measured by reduced growth of resistant colonies 
(solid line, light grey shading) relative to sensitive colonies (dashed line, dark grey shading) 
when grown in the absence of bacteriocin. Predicted OD (+/- 95% CI of mean) for two sensitive 
colonies and nine resistant colonies isolated from one replicate of the main experiment are shown 
in (A), while growth of five sensitive and five resistant colonies isolated from an independent 
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